GB0921348D0 - No title - Google Patents
No titleInfo
- Publication number
- GB0921348D0 GB0921348D0 GBGB0921348.9A GB0921348A GB0921348D0 GB 0921348 D0 GB0921348 D0 GB 0921348D0 GB 0921348 A GB0921348 A GB 0921348A GB 0921348 D0 GB0921348 D0 GB 0921348D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- title
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/205—Aptamer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11405808P | 2008-11-12 | 2008-11-12 | |
| US11404508P | 2008-11-12 | 2008-11-12 | |
| US11406508P | 2008-11-13 | 2008-11-13 | |
| US15118309P | 2009-02-09 | 2009-02-09 | |
| US27804909P | 2009-10-02 | 2009-10-02 | |
| US25045409P | 2009-10-09 | 2009-10-09 | |
| US25302709P | 2009-10-19 | 2009-10-19 | |
| PCT/US2009/006095 WO2010056337A2 (en) | 2008-11-12 | 2009-11-12 | Methods and systems of using exosomes for determining phenotypes |
| US12/591,226 US7897356B2 (en) | 2008-11-12 | 2009-11-12 | Methods and systems of using exosomes for determining phenotypes |
| US12/658,452 US20100203529A1 (en) | 2008-11-12 | 2010-02-05 | Methods and systems of using exosomes for determining phenotypes |
| US13/009,393 US8278059B2 (en) | 2008-11-12 | 2011-01-19 | Methods and systems of using exosomes for determining phenotypes |
| US13/543,315 US20130005599A1 (en) | 2008-11-12 | 2012-07-06 | Methods and systems of using exosomes for determining phenotypes |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| GB0921348D0 true GB0921348D0 (en) | 2010-01-20 |
| GB2463401A GB2463401A (en) | 2010-03-17 |
| GB2463401A8 GB2463401A8 (en) | 2013-05-15 |
| GB2463401B GB2463401B (en) | 2014-01-29 |
Family
ID=42170590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0921348.9A Expired - Fee Related GB2463401B (en) | 2008-11-12 | 2009-11-12 | Characterizing prostate disorders by analysis of microvesicles |
Country Status (9)
| Country | Link |
|---|---|
| US (6) | US7897356B2 (en) |
| EP (3) | EP2730662A1 (en) |
| JP (3) | JP2012508577A (en) |
| CN (2) | CN102301002A (en) |
| BR (1) | BRPI0921043A2 (en) |
| CA (1) | CA2743211A1 (en) |
| GB (1) | GB2463401B (en) |
| IL (3) | IL212768A (en) |
| WO (1) | WO2010056337A2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114214419A (en) * | 2020-03-30 | 2022-03-22 | 中国医学科学院肿瘤医院 | Kit, device and method for diagnosis of lung cancer |
Families Citing this family (392)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6136311A (en) | 1996-05-06 | 2000-10-24 | Cornell Research Foundation, Inc. | Treatment and diagnosis of cancer |
| US7854756B2 (en) * | 2004-01-22 | 2010-12-21 | Boston Scientific Scimed, Inc. | Medical devices |
| WO2005121369A2 (en) * | 2004-06-02 | 2005-12-22 | Sourcepharm, Inc. | Rna-containing microvesicles and methods therefor |
| US8021847B2 (en) * | 2004-06-02 | 2011-09-20 | Proxy Life Science Holdings, Inc. | Microvesicle-based compositions and methods |
| EP1799840A4 (en) | 2004-09-03 | 2009-02-18 | Univ Columbia | ILT3 POLYPEPTIDES AND USES |
| EP3517151B1 (en) * | 2006-03-09 | 2021-04-21 | Aethlon Medical, Inc. | Extracorporeal removal of microvesicular particles |
| CA2646329C (en) | 2006-03-20 | 2018-07-03 | The Regents Of The University Of California | Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting |
| US12366585B2 (en) | 2006-05-18 | 2025-07-22 | Caris Mpi, Inc. | Molecular profiling of tumors |
| AU2008207735B2 (en) * | 2007-01-26 | 2013-10-03 | University Of Louisville Research Foundation, Inc. | Modification of exosomal components for use as a vaccine |
| WO2008147974A1 (en) | 2007-05-23 | 2008-12-04 | University Of South Florida | Micro-rnas modulating immunity and inflammation |
| US8540752B2 (en) * | 2007-07-03 | 2013-09-24 | Spine Tek, Inc. | Interspinous mesh |
| WO2009015357A1 (en) * | 2007-07-25 | 2009-01-29 | University Of Louisville Research Foundation, Inc. | Exosome-associated microrna as a diagnostic marker |
| US9186405B2 (en) | 2007-08-16 | 2015-11-17 | The Royal Institution For The Advancement Of Learning/Mcgill University | Tumor cell-derived microvesicles |
| US20100255514A1 (en) * | 2007-08-16 | 2010-10-07 | The Royal Institution For The Advancement Of Learning/Mcgill University | Tumor cell-derived microvesicles |
| CA2698343C (en) | 2007-09-04 | 2018-06-12 | The Regents Of The University Of California | High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection |
| BRPI0816852A2 (en) * | 2007-09-14 | 2017-06-06 | Univ Ohio State Res Found | method of diagnosing or predicting disease or disorder in subject, biomarker, method for determining and / or predicting whether subject has disorder differentiation, biomarker for lung disorder, method for diagnosing if subject has, or is at risk of developing disease or disorder, method inhibit the proliferation of disease or disorder and method to identify cancer therapeutic agent. |
| US20100291113A1 (en) * | 2007-10-03 | 2010-11-18 | Cornell University | Treatment of Proliferative Disorders Using Antibodies to PSMA |
| ES2936256T3 (en) * | 2008-02-01 | 2023-03-15 | Massachusetts Gen Hospital | Use of microvesicles in the diagnosis, and prognosis of diseases and medical conditions |
| EP2799557B1 (en) * | 2008-02-28 | 2016-09-07 | The Ohio State University Research Foundation | MiR-32 antagonists for increasing responsiveness of prostate cancer to apoptosis |
| CA2717320A1 (en) * | 2008-03-11 | 2009-09-17 | Sequenom, Inc. | Nucleic acid-based tests for prenatal gender determination |
| PE20150362A1 (en) | 2008-08-12 | 2015-03-20 | Zinfandel Pharmaceuticals Inc | METHOD OF IDENTIFICATION OF RISK FACTORS OF THE DISEASE |
| US8846315B2 (en) | 2008-08-12 | 2014-09-30 | Zinfandel Pharmaceuticals, Inc. | Disease risk factors and methods of use |
| US8962247B2 (en) | 2008-09-16 | 2015-02-24 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
| US8476013B2 (en) | 2008-09-16 | 2013-07-02 | Sequenom, Inc. | Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
| KR100928403B1 (en) * | 2008-10-01 | 2009-11-26 | 경북대학교 산학협력단 | Compositions and kits for diagnosing T.B. nephropathy |
| US9487837B2 (en) | 2008-10-06 | 2016-11-08 | Morehouse School Of Medicine | Exosome-mediated diagnosis of hepatitis virus infections and diseases |
| US10545149B2 (en) * | 2008-10-06 | 2020-01-28 | Morehouse School Of Medicine | Detection of HIV-related proteins in urine |
| US20130184169A1 (en) * | 2008-10-30 | 2013-07-18 | Caris Life Sciences Luxembourg Holdings a Luxembourg corporation | Methods for assessing rna patterns |
| EP2358912B1 (en) * | 2008-10-30 | 2016-10-12 | Caris Life Sciences Switzerland Holdings GmbH | Methods for assessing rna patterns |
| WO2010054233A1 (en) * | 2008-11-08 | 2010-05-14 | The Wistar Institute Of Anatomy And Biology | Biomarkers in peripheral blood mononuclear cells for diagnosing or detecting lung cancers |
| CN102301002A (en) * | 2008-11-12 | 2011-12-28 | 卡里斯生命科学卢森堡控股有限责任公司 | Methods and systems for determining phenotypes using exosomes |
| US20140113310A9 (en) * | 2008-12-05 | 2014-04-24 | Myriad Genetics, Incorporated | Cancer detection markers |
| GB0822836D0 (en) * | 2008-12-15 | 2009-01-21 | Oxford Biomedica Ltd | Method |
| US10517969B2 (en) | 2009-02-17 | 2019-12-31 | Cornell University | Methods and kits for diagnosis of cancer and prediction of therapeutic value |
| CA2754412A1 (en) * | 2009-03-31 | 2010-10-14 | The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services | Differentially expressed micrornas as biomarkers for the diagnosis and treatment of sjogren's syndrome |
| GB0906643D0 (en) * | 2009-04-17 | 2009-06-03 | Wilson Stuart M | Detection of bacteria and fungi |
| WO2011031892A1 (en) * | 2009-09-09 | 2011-03-17 | The General Hospital Corporation | Use of microvesicles in analyzing kras mutations |
| WO2011031877A1 (en) | 2009-09-09 | 2011-03-17 | The General Hospital Corporation | Use of microvesicles in analyzing nucleic acid profiles |
| EP2316972A1 (en) * | 2009-10-29 | 2011-05-04 | Deutsches Krebsforschungszentrum | Circulating miRNAs as non-invasive markers for diagnosis and staging in prostate cancer |
| EP2496714B1 (en) | 2009-11-04 | 2016-08-31 | DiamiR, LLC | Methods of using micro-rna from bodily fluids for diagnosis and monitoring of mild cognitive impairment |
| EP2506876B1 (en) | 2009-12-02 | 2016-10-12 | Imaginab, Inc. | J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use |
| US9926593B2 (en) | 2009-12-22 | 2018-03-27 | Sequenom, Inc. | Processes and kits for identifying aneuploidy |
| WO2011083145A1 (en) * | 2010-01-08 | 2011-07-14 | Cavadis B.V. | Determination of exosomel biomarkers for predicting cardiovascular events |
| US8236574B2 (en) | 2010-03-01 | 2012-08-07 | Quanterix Corporation | Ultra-sensitive detection of molecules or particles using beads or other capture objects |
| US9110025B2 (en) | 2010-03-01 | 2015-08-18 | Quanterix Corporation | Methods and systems for extending dynamic range in assays for the detection of molecules or particles |
| CA2791905A1 (en) * | 2010-03-01 | 2011-09-09 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Biomarkers for theranostics |
| CN101955991B (en) * | 2010-03-31 | 2014-05-28 | 江苏迈迪基因生物科技有限公司 | Joint detection method of fusion genes related to leukemia and diagnosis kit |
| CA2795776A1 (en) * | 2010-04-06 | 2011-10-13 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Circulating biomarkers for disease |
| WO2011156734A2 (en) * | 2010-06-11 | 2011-12-15 | Hitachi Chemical Co., Ltd. | Method of characterizing vascular diseases |
| WO2011156763A1 (en) | 2010-06-11 | 2011-12-15 | Hitachi Chemical Co., Ltd. | Methods for characterizing kidney function |
| CN101955995B (en) * | 2010-06-17 | 2013-06-26 | 江苏迈迪基因生物科技有限公司 | Combined detection method and diagnostic kit of fusion genes related to lymphoma |
| US20120015830A1 (en) * | 2010-06-21 | 2012-01-19 | Diogenix, Inc. | Microrna profiles for evaluating multiple sclerosis |
| EP2591359B1 (en) * | 2010-07-07 | 2017-03-01 | Aethlon Medical Inc | Methods for quantifying exosomes |
| WO2012010584A1 (en) * | 2010-07-20 | 2012-01-26 | Febit Holding Gmbh | Complex mirna sets as novel biomarkers for gastric cancer |
| WO2012017430A2 (en) | 2010-08-01 | 2012-02-09 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Microrna patterns for the diagnosis, prognosis and treatment of melanoma |
| AU2011291599B2 (en) * | 2010-08-18 | 2015-09-10 | Caris Life Sciences Switzerland Holdings Gmbh | Circulating biomarkers for disease |
| WO2012031008A2 (en) * | 2010-08-31 | 2012-03-08 | The General Hospital Corporation | Cancer-related biological materials in microvesicles |
| WO2012040500A2 (en) * | 2010-09-22 | 2012-03-29 | Hoon Dave S B | Direct blood assay for detection of circulating microrna in cancer patients |
| AU2011316477A1 (en) * | 2010-10-11 | 2013-05-02 | Medsaic Pty Ltd | Assay for disease detection |
| KR20120037576A (en) * | 2010-10-12 | 2012-04-20 | 주식회사 엘지실트론 | Sawing apparatus of single crystal and sawing method of single crystal |
| CN101942523B (en) * | 2010-10-15 | 2013-04-03 | 邵棠 | Liquid-phase chip method for detecting PCA3 gene and PSA gene and diagnostic reagent kit thereof |
| EP2638057B1 (en) | 2010-11-10 | 2019-03-06 | Exosome Diagnostics, Inc. | Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom |
| JP6109744B2 (en) | 2010-11-12 | 2017-04-05 | インセルディーエックス・インコーポレーテッド | Method and system for predicting whether a subject has a cervical intraepithelial neoplasia (CIN) lesion from a floating sample of cervical cells |
| SG190245A1 (en) * | 2010-11-12 | 2013-06-28 | Endocyte Inc | Methods of treating cancer |
| CA2824050A1 (en) | 2011-01-10 | 2012-07-19 | Zinfandel Pharmaceuticals, Inc. | Methods and drug products for treating alzheimer's disease |
| US9952237B2 (en) | 2011-01-28 | 2018-04-24 | Quanterix Corporation | Systems, devices, and methods for ultra-sensitive detection of molecules or particles |
| SG183579A1 (en) * | 2011-02-11 | 2012-09-27 | Agency Science Tech & Res | Methods of detecting therapeutic exosomes |
| WO2012112865A2 (en) * | 2011-02-17 | 2012-08-23 | Cornell University | Compositions and methods to prevent cell transformation and cancer metastasis |
| WO2012110099A1 (en) * | 2011-02-18 | 2012-08-23 | Cavadis B.V. | Determination of exosomal biomarkers for predicting cardiovascular events |
| WO2012110253A2 (en) * | 2011-02-18 | 2012-08-23 | Cavadis B.V. | Exosomal biomarkers for cardiovascular events |
| AU2012220872A1 (en) * | 2011-02-22 | 2013-09-12 | Caris Life Sciences Switzerland Holdings Gmbh | Circulating biomarkers |
| WO2012122499A2 (en) | 2011-03-09 | 2012-09-13 | Pestell Richard G | Prostate cancer cell lines, gene signatures and uses thereof |
| ITNA20110012A1 (en) * | 2011-03-14 | 2012-09-15 | Amal Raj Delfin Albert | INSULATION AND PURIFICATION PROCEDURE OF URINARY EXOSOMES FOR RESEARCH OF PROTEIN BIOMARCERS |
| US20120289420A1 (en) * | 2011-03-18 | 2012-11-15 | University Of South Florida | Microrna biomarkers for airway diseases |
| EP2688904B1 (en) | 2011-03-21 | 2017-12-27 | Atlantic Cancer Research Institute | Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy |
| US8399262B2 (en) | 2011-03-23 | 2013-03-19 | Darrel A. Mazzari | Biosensor |
| WO2012135844A2 (en) * | 2011-04-01 | 2012-10-04 | Cornell University | Circulating exosomes as diagnostic/prognostic indicators and therapeutic targets of melanoma and other cancers |
| JP6211511B2 (en) | 2011-04-18 | 2017-10-11 | ディアミール, エルエルシーDiamir, Llc | Universal screening test (UST) based on miRNA |
| US8455221B2 (en) | 2011-04-29 | 2013-06-04 | Sequenom, Inc. | Quantification of a minority nucleic acid species |
| US20140155280A1 (en) * | 2011-05-05 | 2014-06-05 | Commonwealth Scientific And Industrial Research Organisation | Method of diagnosing neoplasms |
| ES2744589T3 (en) * | 2011-05-11 | 2020-02-25 | Exosome Diagnostics Inc | Nucleic acid extraction from heterogeneous biological materials |
| US9932635B2 (en) * | 2011-05-24 | 2018-04-03 | The Regents Of The University Of California | Method for exosomal biomarker detection by electric field-induced release and measurement |
| AU2012267884A1 (en) * | 2011-06-07 | 2014-01-23 | Caris Life Sciences Switzerland Holdings Gmbh | Circulating biomarkers for cancer |
| JP5823031B2 (en) | 2011-06-10 | 2015-11-25 | 日立化成株式会社 | Vesicle capture device and method for using the same |
| CN103797131A (en) * | 2011-06-16 | 2014-05-14 | 卡里斯生命科学卢森堡控股有限责任公司 | Biomarker compositions and methods |
| US9771617B2 (en) * | 2011-06-27 | 2017-09-26 | Eisai R&D Management Co., Ltd. | Microrna biomarkers indicative of alzheimer's disease |
| US20130028895A1 (en) | 2011-07-27 | 2013-01-31 | Gerald Wulf | Exosome inhibiting agents and uses thereof |
| WO2013019714A1 (en) | 2011-07-29 | 2013-02-07 | The Trustees Of Columbia University In The City Of New York | Mems affinity sensor for continuous monitoring of analytes |
| EP2739754A4 (en) * | 2011-08-05 | 2015-01-21 | Univ Louisville Res Found | Microrna biomarkers |
| AU2012294458A1 (en) * | 2011-08-08 | 2014-02-27 | Caris Life Sciences Switzerland Holdings Gmbh | Biomarker compositions and methods |
| US20130040303A1 (en) * | 2011-08-08 | 2013-02-14 | Eugenia Wang | Biomarker for Alzheimer's Disease and/or Mild Cognitive Impairment, and Use Thereof |
| EP3156505B1 (en) * | 2011-08-19 | 2019-07-17 | Hummingbird Diagnostics GmbH | Complex sets of mirnas as non-invasive biomarkers for colon cancer |
| WO2013033734A1 (en) | 2011-09-02 | 2013-03-07 | The Trustees Of Columbia University In The City Of New York | Diagnosis and Treatment of Cancer Expressing ILT3 or ILT3 Ligand |
| US20130079241A1 (en) | 2011-09-15 | 2013-03-28 | Jianhua Luo | Methods for Diagnosing Prostate Cancer and Predicting Prostate Cancer Relapse |
| AU2013201774A1 (en) | 2011-09-16 | 2013-04-18 | University Of Louisville Research Foundation, Inc. | Methods of predicting and decreasing the risk of pre-term birth |
| EP2758774A4 (en) * | 2011-09-22 | 2015-04-29 | Univ Los Andes | METHOD FOR MONITORING, DIAGNOSING AND / OR PROGNOSING ACUTE RENAL INJURY IN THE EARLY STAGE |
| US20130095575A1 (en) * | 2011-10-03 | 2013-04-18 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for Fractionation, Analysis and Collection of Microvesicles From Patient Samples |
| CA2852098C (en) | 2011-10-21 | 2023-05-02 | Chronix Biomedical | Colorectal cancer associated circulating nucleic acid biomarkers |
| NO3051026T3 (en) * | 2011-10-21 | 2018-07-28 | ||
| WO2013070324A1 (en) | 2011-11-07 | 2013-05-16 | University Of Louisville Research Foundation, Inc. | Edible plant-derived microvesicle compositions for diagnosis and treatment of disease |
| CN102443649A (en) * | 2011-12-20 | 2012-05-09 | 苏州福英基因科技有限公司 | Kit for detecting horizontal in situ hybridization of MICRORNA-141 at early stage of pathological evolution of various cancers, detection method and application |
| EP2801822B1 (en) * | 2011-12-22 | 2017-08-30 | Theoria Science Inc. | Exosome analysis method, reagent for use in analysis of exosome, and exosome analysis apparatus |
| US9422592B2 (en) | 2012-01-06 | 2016-08-23 | Viomics, Inc. | System and method of detecting RNAS altered by cancer in peripheral blood |
| US9879254B2 (en) | 2012-01-18 | 2018-01-30 | The General Hosptial Corporation | Targeting RNAs to microvesicles |
| WO2013119602A1 (en) | 2012-02-06 | 2013-08-15 | President And Fellows Of Harvard College | Arrdc1-mediated microvesicles (armms) and uses thereof |
| US9726668B2 (en) | 2012-02-09 | 2017-08-08 | Memed Diagnostics Ltd. | Signatures and determinants for diagnosing infections and methods of use thereof |
| HK1206055A1 (en) | 2012-03-02 | 2015-12-31 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| CA2867118A1 (en) * | 2012-03-13 | 2013-09-19 | Baylor Research Institute | Early detection of tuberculosis treatment response |
| US20130280720A1 (en) * | 2012-03-15 | 2013-10-24 | The University Of Kansas | Tissue biomarkers for indication of progression from barrett's esophagus to esophageal adenocarcinoma |
| ES2655184T3 (en) | 2012-05-03 | 2018-02-19 | Medial Research Ltd. | Methods and systems for assessing a risk of gastrointestinal cancer |
| US20150141470A1 (en) | 2012-05-08 | 2015-05-21 | The Broad Institute, Inc. | Diagnostic and treatment methods in patients having or at risk of developing resistance to cancer therapy |
| US9334498B2 (en) | 2012-05-10 | 2016-05-10 | Uab Research Foundation | Methods and compositions for modulating MIR-204 activity |
| EP2861302A4 (en) | 2012-05-14 | 2016-08-24 | Prostagene Llc | Using modulators of ccr5 for treating cancer |
| US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
| US10504613B2 (en) | 2012-12-20 | 2019-12-10 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US9702886B2 (en) | 2012-05-24 | 2017-07-11 | The Broad Institute, Inc. | Methods and devices for tuberculosis diagnosis using biomarker profiles |
| US9493810B2 (en) * | 2012-06-07 | 2016-11-15 | Pioma, Inc. | 5-ALA for detection of brain tumors |
| JPWO2014003053A1 (en) * | 2012-06-27 | 2016-06-02 | 国立研究開発法人国立がん研究センター | Pancreatic cancer detection method and detection kit |
| WO2014011928A1 (en) | 2012-07-13 | 2014-01-16 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
| WO2014015149A2 (en) * | 2012-07-18 | 2014-01-23 | Exosome Diagnostics, Inc. | Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions |
| WO2014012168A1 (en) * | 2012-07-19 | 2014-01-23 | Anirban Ghosh | Method for the isolation of microvesicles |
| DK2687607T3 (en) * | 2012-07-19 | 2015-04-07 | St Josef Und St Elisabeth Hospital Gmbh | MicroRNA-profiles in the diagnosis of multiple sclerosis |
| EP2885414B1 (en) | 2012-08-15 | 2020-09-23 | The University of Chicago | Exosome-based therapeutics against neurodegenerative disorders |
| WO2014028862A1 (en) | 2012-08-17 | 2014-02-20 | Cornell University | Use of dna in circulating exosomes as a diagnostic marker for metastasic disease |
| JP5933010B2 (en) | 2012-08-20 | 2016-06-08 | 国立研究開発法人国立がん研究センター | Cancer treatment |
| KR102226813B1 (en) | 2012-09-04 | 2021-03-11 | 매드-로직스 아이엔씨. | Tissue removal devices, systems and methods |
| WO2014059336A1 (en) | 2012-10-12 | 2014-04-17 | University Of Notre Dame Du Lac | Exosomes and diagnostic biomarkers |
| ES2912033T3 (en) * | 2012-10-23 | 2022-05-24 | Caris Science Inc | Aptamers and uses thereof |
| US10942184B2 (en) | 2012-10-23 | 2021-03-09 | Caris Science, Inc. | Aptamers and uses thereof |
| WO2014078420A1 (en) | 2012-11-13 | 2014-05-22 | Allan Wu | Methods and systems for processing exosomes |
| KR101984700B1 (en) | 2012-11-19 | 2019-05-31 | 삼성전자주식회사 | Polynucleotide and use thereof |
| WO2014093698A1 (en) | 2012-12-12 | 2014-06-19 | The Methodist Hospital Research Institute | Multi-aptamer-based, cell-specific, one-step tumor cell detection assays |
| EP2746406B1 (en) | 2012-12-18 | 2017-08-23 | Samsung Electronics Co., Ltd. | Composition and kit for diagnosing breast cancer including miRNAs within vesicle, and method of diagnosing breast cancer using the same |
| EP2935628B1 (en) * | 2012-12-19 | 2018-03-21 | Caris Life Sciences Switzerland Holdings GmbH | Compositions and methods for aptamer screening |
| CA2897340C (en) * | 2013-01-09 | 2022-09-06 | Friedrich-Alexander-Universitat Erlangen-Nuernberg | Method for in vitro detection and monitoring of a disease by measuring disease-associated protease activity in extracellular vesicles |
| WO2014159662A1 (en) | 2013-03-13 | 2014-10-02 | University Of Miami | Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids |
| EP2971100A1 (en) | 2013-03-13 | 2016-01-20 | Sequenom, Inc. | Primers for dna methylation analysis |
| BR112015023275B1 (en) * | 2013-03-15 | 2022-06-21 | Board Of Regents, The University Of Texas System | In vitro method of cancer biomarker detection |
| AU2014227883B9 (en) * | 2013-03-15 | 2020-09-10 | Life Technologies Corporation | Classification and actionability indices for lung cancer |
| KR101504817B1 (en) * | 2013-04-05 | 2015-03-24 | 연세대학교 산학협력단 | Novel system for predicting prognosis of locally advanced gastric cancer |
| EP2985605A4 (en) * | 2013-04-08 | 2017-02-15 | Theoria Science Inc. | Method for detecting colon cancer |
| SG11201508433TA (en) | 2013-04-12 | 2015-11-27 | Andaloussi Samir El | Therapeutic delivery vesicles |
| EP2986326B1 (en) * | 2013-04-15 | 2018-09-05 | Cedars-Sinai Medical Center | Methods for detecting cancer metastasis |
| JP6297676B2 (en) | 2013-05-06 | 2018-03-20 | 日立化成株式会社 | Devices and methods for capturing target molecules |
| US20160090637A1 (en) * | 2013-05-14 | 2016-03-31 | Wei Chen | Pharmacogenomic Biomarkers for B Cell Malignancies and Methods of Use Thereof |
| MX361092B (en) * | 2013-05-23 | 2018-11-26 | Iphenotype Llc | Phenotypic integrated social search database and method. |
| JP6529486B2 (en) | 2013-06-05 | 2019-06-12 | バイオタイム インク．Ｂｉｏｔｉｍｅ Ｉｎｃ． | Compositions and methods for induced tissue regeneration in mammalian species |
| CN104237168B (en) * | 2013-06-21 | 2017-12-12 | 国家纳米科学中心 | A kind of method for detecting fluid sample China and foreign countries utricule |
| US9213029B2 (en) | 2013-06-25 | 2015-12-15 | Samsung Electronics Co., Ltd. | Method for diagnosing breast cancer by detection of polymeric immunoglobulin receptor in vesicles isolated from patients |
| MX377339B (en) | 2013-08-28 | 2025-03-06 | Abbvie Stemcentrx Llc | SITE-SPECIFIC ANTIBODY CONJUGATION METHODS AND COMPOSITIONS. |
| CN105980615A (en) * | 2013-08-28 | 2016-09-28 | 卡里斯生命科学瑞士控股有限公司 | Oligonucleotide probes and uses thereof |
| JPWO2015045666A1 (en) * | 2013-09-25 | 2017-03-09 | 国立大学法人 東京大学 | Fluid device, exosome analysis method, biomolecule analysis method, and biomolecule detection method |
| JP6531989B2 (en) * | 2013-09-25 | 2019-06-19 | 国立大学法人 東京大学 | Solution mixing method |
| RU2663908C1 (en) * | 2013-09-30 | 2018-08-13 | Федеральное государственное бюджетное учреждение науки Институт молекулярной генетики РАН | Method for identification of genetic markers of later form of parkinson disease |
| US20160237496A1 (en) * | 2013-10-02 | 2016-08-18 | Hitachichemical Company Ltd. | Methods for assessing status of post-transplant liver and determining and administering specific treatment regimens |
| ES2813699T3 (en) | 2013-11-18 | 2021-03-24 | Diamir Llc | Methods of using miRNA from body fluids for the detection and monitoring of Parkinson's disease (PD) |
| WO2015074083A1 (en) * | 2013-11-18 | 2015-05-21 | The Trustees Of Columbia University In The City Of New York | Methods for diagnosing t cell-mediated inflammation |
| JP6128621B2 (en) * | 2013-12-04 | 2017-05-17 | 国立研究開発法人産業技術総合研究所 | Nucleic acid aptamers for microvesicles |
| WO2015083829A1 (en) * | 2013-12-06 | 2015-06-11 | 国立大学法人東京大学 | Valve, fluid-controlling structure, fluid device, and method for manufacturing valve |
| CN103714268A (en) * | 2013-12-12 | 2014-04-09 | 深圳先进技术研究院 | Method of screening multiple sclerosis biomarkers |
| CA2935216C (en) | 2013-12-30 | 2021-11-09 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Fusion genes associated with progressive prostate cancer |
| WO2015112382A1 (en) | 2014-01-21 | 2015-07-30 | Morehouse School Of Medicine | Exosome-mediated detection of infections and diseases |
| US11078462B2 (en) | 2014-02-18 | 2021-08-03 | ReCyte Therapeutics, Inc. | Perivascular stromal cells from primate pluripotent stem cells |
| US10260105B2 (en) | 2014-02-18 | 2019-04-16 | Baylor Research Institute | MiR-320e and colorectal cancer |
| EP3107576A4 (en) | 2014-02-21 | 2017-09-06 | Abbvie Stemcentrx LLC | Anti-dll3 antibodies and drug conjugates for use in melanoma |
| JP6415829B2 (en) * | 2014-02-28 | 2018-10-31 | キヤノンメディカルシステムズ株式会社 | Method for determining characteristics of exosomes contained in specimen, diagnostic method and apparatus |
| EP3736344A1 (en) | 2014-03-13 | 2020-11-11 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| EP3122905B1 (en) | 2014-03-27 | 2020-09-09 | Yale University | Circulating micrornas as biomarkers for endometriosis |
| WO2015153732A2 (en) * | 2014-04-01 | 2015-10-08 | Cornell University | Use of double-stranded dna in exosomes: a novel biomarker in cancer detection |
| US20170035700A1 (en) | 2014-04-11 | 2017-02-09 | University Of Louisville Research Foundation, Inc. | Coated edible plant-derived microvesicle compositions and methods for using the same |
| CN103954770B (en) * | 2014-04-25 | 2015-09-30 | 江南大学 | EVs-TRPC5 is detecting the application in breast carcinoma resistance degree |
| EP3146346A4 (en) * | 2014-05-23 | 2018-03-21 | Georgetown University | Exosome and lipid biomarkers for memory loss |
| WO2015179909A1 (en) * | 2014-05-26 | 2015-12-03 | The University Of Melbourne | Mirna biomarkers of alzheimer's disease |
| EP3152579A4 (en) * | 2014-06-04 | 2018-01-17 | Atossa Genetics Inc. | Molecular mammography |
| AU2015270450B2 (en) * | 2014-06-06 | 2021-04-01 | Exosomics S.p.A. | Use of TM9SF4 as a biomarker for tumor associated exosomes |
| JP6531171B2 (en) * | 2014-06-27 | 2019-06-12 | エックスワイ エバーグリーン テクノロジー カンパニー | Methods for enriching CNS derived exosomes |
| US10240127B2 (en) * | 2014-07-03 | 2019-03-26 | ReCyte Therapeutics, Inc. | Exosomes from clonal progenitor cells |
| US20180209975A1 (en) * | 2014-07-17 | 2018-07-26 | The Trustees Of The University Of Pennsylvania | Methods for using exosomes to monitor transplanted organ status |
| WO2016011428A1 (en) * | 2014-07-17 | 2016-01-21 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods of treating cells containing fusion genes |
| WO2016011383A1 (en) * | 2014-07-17 | 2016-01-21 | The Trustees Of The University Of Pennsylvania | Methods for using exosomes to monitor transplanted organ status |
| WO2016022696A1 (en) | 2014-08-05 | 2016-02-11 | The Trustees Of Columbia University In The City Of New York | Method of isolating aptamers for minimal residual disease detection |
| CA2956723C (en) | 2014-08-12 | 2023-04-11 | Nextgen Jane, Inc. | System and method for monitoring health based on collected bodily fluid |
| SG10201404895XA (en) * | 2014-08-13 | 2016-03-30 | Agency Science Tech & Res | Diagnosis |
| EP2985289A1 (en) * | 2014-08-14 | 2016-02-17 | Miltenyi Biotec GmbH | Depletion of mouse cells for generic isolation of human cells upon xenotransplantation |
| CA3190715A1 (en) | 2014-08-14 | 2016-02-18 | Memed Diagnostics Ltd. | Computational analysis of biological data using manifold and a hyperplane |
| US20170283789A1 (en) * | 2014-08-29 | 2017-10-05 | Hitachi Chemical Co., Ltd. | Methods for collecting cervical-vaginal fluids and isolating exosome and microvesicles for molecular analysis |
| CA2960164A1 (en) * | 2014-09-05 | 2016-03-10 | Exerkine Corporation | Methods of producing and using exersomes and bioengineered exersomes |
| JP6669731B2 (en) * | 2014-09-12 | 2020-03-18 | パナシア ファーマシューティカルズ， インコーポレイテッド | Recovery of aspartyl (asparaginyl) beta hydroxylase (HAAH) from the exosome fraction of human serum from cancer patients |
| US11397182B2 (en) | 2014-10-07 | 2022-07-26 | Cornell University | Methods for prognosing and preventing metastatic liver disease |
| CN116731958A (en) * | 2014-10-09 | 2023-09-12 | 细胞结构公司 | Placenta-derived adherent cell exosomes and uses thereof |
| WO2016059636A1 (en) | 2014-10-14 | 2016-04-21 | Memed Diagnostics Ltd. | Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof |
| CN104535766B (en) * | 2014-10-30 | 2016-04-13 | 中国人民解放军总医院第一附属医院 | The diagnosing cancer of liver that peripheral blood exosome originates and prognostic marker and application thereof |
| US9816080B2 (en) | 2014-10-31 | 2017-11-14 | President And Fellows Of Harvard College | Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs) |
| US10266895B2 (en) | 2014-11-05 | 2019-04-23 | Hitachi Chemical Company Ltd. | Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease |
| EP3218521B1 (en) | 2014-11-12 | 2019-12-25 | Hitachi Chemical Co., Ltd. | Method for diagnosing organ injury |
| US10093743B2 (en) * | 2014-11-18 | 2018-10-09 | Premkumar Christadoss | Muscle specific tyrosine kinase-fluorophore conjugate compositions, kits and methods of using |
| CN104372004B (en) * | 2014-12-04 | 2018-04-27 | 广东医学院 | One detection method and its application with the susceptible relevant miR-27a Polymorphisms site of myocardial infarction |
| CN107209184B (en) * | 2014-12-11 | 2020-04-24 | 米密德诊断学有限公司 | Marker combinations for diagnosing multiple infections and methods of use thereof |
| WO2016121821A1 (en) * | 2015-01-27 | 2016-08-04 | Jsr株式会社 | Separation method, detection method, signal measurement method, method for determining disease, method for evaluating drug efficacy, kit, liquid composition, and analyte diluent |
| EP3250706A4 (en) * | 2015-01-30 | 2018-09-05 | The Johns Hopkins University | Extracellular vesicles for agent delivery |
| DK3262190T3 (en) | 2015-02-24 | 2021-10-11 | Univ Heidelberg Ruprecht Karls | BIOMARKER PANEL FOR DETECTING CANCER |
| WO2016140388A1 (en) * | 2015-03-05 | 2016-09-09 | 경북대학교 산학협력단 | Organ toxicity diagnostic biomarker composition comprising exosome or protein of same and diagnostic method using same |
| EP3112474A1 (en) * | 2015-06-29 | 2017-01-04 | Evonik Degussa GmbH | Method of detecting avian necrotic enteritis |
| GB201503792D0 (en) * | 2015-03-06 | 2015-04-22 | Imp Innovations Ltd | Method |
| US11971354B2 (en) | 2015-04-08 | 2024-04-30 | Molecular Devices, Llc | Methods and systems for fluorescence detection using infrared dyes |
| US10571396B2 (en) * | 2015-04-08 | 2020-02-25 | Molecular Devices, Llc | Methods and systems for fluorescence detection |
| US10379046B2 (en) * | 2015-04-08 | 2019-08-13 | Molecular Devices, Llc | Method and system for multiplexed time-resolved fluorescence detection |
| WO2016172710A2 (en) | 2015-04-24 | 2016-10-27 | Cornell University | Methods and reagents for determination and treatment of organotropic metastasis |
| EP3093664A1 (en) * | 2015-05-13 | 2016-11-16 | Miltenyi Biotec GmbH | A method for analysing markers on the surface of vesicles |
| CA2988771A1 (en) | 2015-06-09 | 2016-12-15 | The Board Of Regents Of The University Of Texas System | Diagnostic test for early stage cancer |
| IL256175B2 (en) | 2015-06-10 | 2024-10-01 | Univ Texas | Use of exosomes for the treatment of disease |
| IL256634B2 (en) | 2015-06-29 | 2025-08-01 | Caris Science Inc | Therapeutic oligonucleotides |
| WO2017011560A1 (en) * | 2015-07-15 | 2017-01-19 | Hycor Biomedical, Llc. | Customizable instrument |
| US10765742B2 (en) | 2015-07-17 | 2020-09-08 | The Trustees Of Columbia University In The City Of New York | Methods of treating CD166-expressing cancer |
| US10941176B2 (en) | 2015-07-28 | 2021-03-09 | Caris Science, Inc. | Therapeutic oligonucleotides |
| EP3332037B1 (en) | 2015-08-07 | 2021-02-24 | University of Pittsburgh- Of the Commonwealth System of Higher Education | Methods for predicting prostate cancer relapse |
| CN108136012B (en) | 2015-08-07 | 2022-10-04 | 伊麦吉纳博公司 | Antigen binding constructs for targeting molecules |
| CN105039333B (en) * | 2015-08-21 | 2018-07-24 | 天津医科大学 | Hepatoma-targeting peptide and its application |
| JP6606916B2 (en) | 2015-08-21 | 2019-11-20 | 株式会社Ｊｖｃケンウッド | Exosomes capture method |
| US11028443B2 (en) | 2015-08-31 | 2021-06-08 | Showa Denko Materials Co., Ltd. | Molecular methods for assessing urothelial disease |
| EP4343311A3 (en) | 2015-09-22 | 2024-05-22 | Trustees of Boston University | Multiplexed phenotyping of nanovesicles |
| EP3147370A1 (en) * | 2015-09-28 | 2017-03-29 | Rheinische Friedrich-Wilhelms-Universität Bonn | Exosomal microrna in serum as an indicator for the activation of brown and beige fat tissue (bat) |
| US20190250147A1 (en) * | 2015-10-13 | 2019-08-15 | The Trustees Of The University Of Pennsylvania | Methods for using enriched exosomes as a platform for monitoring organ status |
| KR101785795B1 (en) * | 2015-10-30 | 2017-10-13 | 가톨릭대학교 산학협력단 | Biomarker micro rna for predicting prognosis of head and neck squamous cell carcinoma |
| WO2017079736A1 (en) * | 2015-11-06 | 2017-05-11 | The Trustees Of Columbia University In The City Of New York | Exosomal protein profiling for detection of cardiac transplant rejection |
| EP3377895B1 (en) * | 2015-11-20 | 2021-07-21 | Exosome Sciences, Inc. | Exosomal tau as a biomarker for brain disorders |
| WO2017100313A1 (en) | 2015-12-07 | 2017-06-15 | Biotime, Inc. | Methods for the re-derivation of diverse pluripotent stem cell-derive brown fat cells |
| US20170168055A1 (en) * | 2015-12-11 | 2017-06-15 | Expression Pathology, Inc. | SRM/MRM Assays |
| CN105779586B (en) * | 2015-12-28 | 2020-02-07 | 四川农业大学 | Method for separating exosome from animal plasma and detecting purity of exosome |
| US10975436B2 (en) | 2016-01-05 | 2021-04-13 | Diamir, Llc | Methods of using miRNA from bodily fluids for diagnosis and monitoring of neurodevelopmental disorders |
| US10962555B2 (en) | 2016-01-07 | 2021-03-30 | Temple University-Of The Commonwealth System Of Higher Education | Purification, extraction and analyses of fetal neurally-derived exosomes in maternal blood and neonatal neurally-derived exosomes from neonatal blood |
| US11243215B2 (en) * | 2016-01-14 | 2022-02-08 | The Regents Of The University Of California | 3D-exoquant method for the analysis of surface molecules and quantification of tissue-specific exosomes in biological fluids |
| WO2017136430A1 (en) | 2016-02-01 | 2017-08-10 | The Board Of Trustees Of The Leland Stanford Junior University | Exosome-total-isoloation-chip (exotic) device for isolation of exosome-based biomarkers |
| WO2017136676A1 (en) * | 2016-02-05 | 2017-08-10 | Nanoview Diagnostics Inc. | Detection of exosomes having surface markers |
| WO2017149548A1 (en) | 2016-03-03 | 2017-09-08 | Memed Diagnostics Ltd. | Rna determinants for distinguishing between bacterial and viral infections |
| CN108699609A (en) | 2016-03-03 | 2018-10-23 | 米密德诊断学有限公司 | Analysis of RNA for diagnosis of infection type |
| WO2017155894A1 (en) | 2016-03-07 | 2017-09-14 | Cfgenome, Llc | Noninvasive molecular controls |
| US11946927B2 (en) | 2016-03-14 | 2024-04-02 | Musidora Biotechnology Llc | Process and system for identifying individuals having a high risk of inflammatory bowel disease and a method of treatment |
| US10295527B2 (en) | 2016-03-14 | 2019-05-21 | Bruce Yacyshyn | Process and system for predicting responders and non-responders to mesalamine treatment of ulcerative colitis |
| JP2019510226A (en) * | 2016-03-15 | 2019-04-11 | バイオメリカ・インコーポレイテッドＢｉｏｍｅｒｉｃａ， Ｉｎｃ． | Composition, device and method for fibromyalgia susceptibility testing |
| EP4339288A3 (en) | 2016-03-18 | 2024-06-05 | Caris Science, Inc. | Oligonucleotide probes and uses thereof |
| ES2993025T3 (en) | 2016-03-21 | 2024-12-20 | Diamir Llc | Methods of using mirnas from bodily fluids for detection and differentiation of neurodegenerative diseases |
| WO2017180909A1 (en) | 2016-04-13 | 2017-10-19 | Nextgen Jane, Inc. | Sample collection and preservation devices, systems and methods |
| US11702702B2 (en) | 2016-04-15 | 2023-07-18 | Predicine, Inc. | Systems and methods for detecting genetic alterations |
| WO2018057820A1 (en) | 2016-09-21 | 2018-03-29 | Predicine, Inc. | Systems and methods for combined detection of genetic alterations |
| US11293017B2 (en) | 2016-05-25 | 2022-04-05 | Caris Science, Inc. | Oligonucleotide probes and uses thereof |
| CN105893782A (en) * | 2016-05-26 | 2016-08-24 | 江苏省人民医院 | Prostatic cancer risk predicting device |
| US9933440B2 (en) | 2016-05-31 | 2018-04-03 | Edward J. Goetzl | Drug efficacy test method for dementias utilizing astrocyte-derived exosomes |
| EP3482201B1 (en) | 2016-07-10 | 2022-12-14 | Memed Diagnostics Ltd. | Early diagnosis of infections |
| EP4141448A1 (en) | 2016-07-10 | 2023-03-01 | MeMed Diagnostics Ltd. | Protein signatures for distinguishing between bacterial and viral infections |
| IL247368A0 (en) | 2016-08-18 | 2016-11-30 | Yeda Res & Dev | Diagnostic and therapeutic uses of exosomes |
| CN106244705B (en) * | 2016-08-29 | 2019-10-11 | 北京泱深生物信息技术有限公司 | Application of the ERC1 in preparation diagnosis or treatment hypopharyngeal cancer tool |
| BR112019004075A2 (en) | 2016-08-30 | 2019-05-28 | Univ Yale | methods for diagnosing an individual with suspected endometriosis, for detecting mirna, for diagnosing an individual who has symptoms of endometriosis or with suspected endometriosis, for treating an individual with endometriosis, for diagnosing and treating an individual with suspected endometriosis, for diagnosing endometriosis in an individual, to diagnose or provide a prognosis for endometriosis in an individual and to monitor a response to an endometriosis treatment in an individual, and, kit. |
| US10914748B2 (en) | 2016-09-08 | 2021-02-09 | UNIVERSITé LAVAL | Erythrocyte-derived extracellular vesicles as a biomarker for clinically assessing Parkinson's disease |
| WO2018060998A1 (en) | 2016-09-29 | 2018-04-05 | Memed Diagnostics Ltd. | Methods of prognosis and treatment |
| EP3519834A4 (en) | 2016-09-29 | 2020-06-17 | MeMed Diagnostics Ltd. | Methods of risk assessment and disease classification |
| US11730823B2 (en) | 2016-10-03 | 2023-08-22 | President And Fellows Of Harvard College | Delivery of therapeutic RNAs via ARRDC1-mediated microvesicles |
| US20200063208A1 (en) * | 2016-10-13 | 2020-02-27 | University Of Louisville Research Foundation, Inc. | Exosomal biomarkers for diagnosis and prognosis of cancer and related methods |
| WO2018075825A1 (en) * | 2016-10-19 | 2018-04-26 | Northwestern University | Extracellular vesicle-based diagnostics and engineered exosomes for targeted therapeutics against cancer |
| CN110168069A (en) * | 2016-10-19 | 2019-08-23 | 通用自动化实验技术公司 | For screening high resolution system, the kit, device and method of microorganism and the application of other high-flux microorganisms |
| JP6712737B2 (en) * | 2016-10-28 | 2020-06-24 | 公益財団法人がん研究会 | Biomarker, disease-related gene search method, and renal cancer marker |
| JP6280997B1 (en) * | 2016-10-31 | 2018-02-14 | 株式会社Preferred Networks | Disease onset determination device, disease onset determination method, disease feature extraction device, and disease feature extraction method |
| WO2018089541A1 (en) | 2016-11-08 | 2018-05-17 | Cedars-Sinai Medical Center | Methods for diagnosing cancer |
| WO2018094469A1 (en) * | 2016-11-24 | 2018-05-31 | The Council Of The Queensland Institute Of Medical Research | Determining a cancer prognosis |
| JP6918062B2 (en) * | 2017-01-19 | 2021-08-11 | シスメックス株式会社 | How to evaluate the differentiation status of cells |
| JP6629770B2 (en) * | 2017-01-19 | 2020-01-15 | シスメックス株式会社 | Method for assessing cell differentiation status |
| US11266745B2 (en) | 2017-02-08 | 2022-03-08 | Imaginab, Inc. | Extension sequences for diabodies |
| US20180246112A1 (en) * | 2017-02-28 | 2018-08-30 | University Of Kentucky Research Foundation | Biomarkers of Breast and Lung Cancer |
| JP2020076572A (en) * | 2017-03-14 | 2020-05-21 | 国立大学法人大阪大学 | Tissue fibrosis biomarker |
| JP2020079708A (en) * | 2017-03-14 | 2020-05-28 | 国立大学法人大阪大学 | Chronic obstructive pulmonary disease biomarker |
| JP2020079707A (en) * | 2017-03-14 | 2020-05-28 | 国立大学法人大阪大学 | Obstructive pulmonary disease biomarker |
| CA3056337A1 (en) | 2017-03-21 | 2018-09-27 | Exoprother Medical Ltd. | Native cell derived vesicles containing tumor suppressor proteins for therapy |
| US11079374B2 (en) * | 2017-03-24 | 2021-08-03 | Dapi Meng Lin CHIANG | Methods and kits for exosome isolation and quantification |
| JP2018178919A (en) * | 2017-04-18 | 2018-11-15 | トヨタ自動車株式会社 | Vehicle control device |
| HUE062498T2 (en) | 2017-05-12 | 2023-11-28 | Evonik Operations Gmbh | Procedure for detection of diseases caused by C. perfringens in bird flocks |
| EP3633376A4 (en) | 2017-06-02 | 2020-12-16 | Limited Liability Company "Prostagnost" | Protein marker for diagnosing prostate cancer, method for measuring the quantity of a marker and algorithm for interpreting the result |
| WO2019008414A1 (en) * | 2017-07-05 | 2019-01-10 | Datar Rajan | Exosome based gene expression analysis for cancer management |
| US10209260B2 (en) | 2017-07-05 | 2019-02-19 | Memed Diagnostics Ltd. | Signatures and determinants for diagnosing infections and methods of use thereof |
| US11899024B2 (en) | 2017-07-12 | 2024-02-13 | Exosome Diagnostics, Inc. | Treatment and diagnosis of parkinson's disease using isolated and enriched populations of biofluid-derived extracellular vesicles |
| US10781487B2 (en) | 2017-07-24 | 2020-09-22 | Diamir, Llc | miRNA-based methods for detecting and monitoring aging |
| CN107245529A (en) * | 2017-08-08 | 2017-10-13 | 杭州千麦医学检验所有限公司 | Blood disease fusion screening method |
| US20190049455A1 (en) * | 2017-08-11 | 2019-02-14 | Panacea Pharmaceuticals Inc. | HAAH and MMP-9 are Complementary Cancer Biomarkers and Predictors of Metastasis when Combined |
| WO2019038660A1 (en) * | 2017-08-21 | 2019-02-28 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Exosome profiling for diagnosis and monitoring of vasculitis and vasculopathies including kawasaki disease |
| WO2019051546A1 (en) * | 2017-09-13 | 2019-03-21 | The Flinders University Of South Australia | Methods and markers for assessing a response to a drug |
| GB2574785A (en) * | 2017-09-15 | 2019-12-25 | Jan Loetvall | Method and system for identifying membrane proteins on extracellular vesicles |
| CN107860830A (en) * | 2017-10-10 | 2018-03-30 | 暨南大学 | Application of the biomarker in its targeted drug in a kind of psoriasis vulgaris blood plasma |
| KR102080887B1 (en) * | 2017-11-07 | 2020-02-24 | 고려대학교 산학협력단 | Composition for diagnosing or prognosing lung cancer including exosome based gcc2 gene and protein |
| US12000834B2 (en) | 2017-11-10 | 2024-06-04 | Mayo Foundation For Medical Education And Research | Methods and materials for assessing and treating cancer |
| US12036262B2 (en) | 2017-11-22 | 2024-07-16 | University Of Louisville Research Foundation, Inc. | Edible plant-derived nanoparticles for regulation of gut microbiota |
| US20210285952A1 (en) * | 2017-12-01 | 2021-09-16 | Cornell University | Nanoparticles and distinct exosome subsets for detection and treatment of cancer |
| WO2019126168A1 (en) * | 2017-12-21 | 2019-06-27 | Proplex Technologies, LLC | Sensitive detection of g-protein coupled receptor-associated sorting protein 1 (gasp-1). gasp-1 microvesicles, and gasp-1 exosomes |
| CN111512158B (en) * | 2017-12-22 | 2023-12-12 | 威斯康星校友研究基金会 | Nanoengineered surfaces for cancer biomarker capture |
| WO2019139901A1 (en) * | 2018-01-12 | 2019-07-18 | Massachusetts Eye And Ear Infirmary | Nasal exosomes for non-invasive sampling of cns proteins |
| EP3740567A4 (en) * | 2018-01-18 | 2022-03-09 | Nanosomix Inc. | Detection of exosomes and exosomal biomarkers for the diagnosis and prognosis of diseases and disorders |
| CN110133272A (en) * | 2018-02-09 | 2019-08-16 | 北京大学 | Method for enrichment or detection of astrocyte-derived exosomes from biological fluids |
| CN110157801B (en) * | 2018-02-12 | 2021-03-09 | 清华大学 | Combined marker, application of combined marker in preparation of gastric cancer occurrence risk prediction kit, and determination system and method of combined marker |
| MX2020009044A (en) | 2018-03-02 | 2020-10-12 | Evonik Operations Gmbh | In vitro method for detecting intestinal barrier failure in animals. |
| CN108103201B (en) * | 2018-03-05 | 2022-03-01 | 江苏为真生物医药技术股份有限公司 | Application of exosome microRNA molecular marker and kit for diagnosing esophageal cancer |
| CN108531586B (en) * | 2018-03-19 | 2022-03-29 | 朱伟 | Circulating miRNA marker on X chromosome related to breast cancer auxiliary diagnosis and application thereof |
| AU2019242912B2 (en) | 2018-03-28 | 2025-07-17 | Board Of Regents, The University Of Texas System | Identification of epigenetic alterations in DNA isolated from exosomes |
| CN108707663B (en) * | 2018-04-19 | 2022-03-08 | 深圳华大基因股份有限公司 | Reagents, preparation methods and applications for the evaluation of quantitative results of miRNA sequencing in cancer samples |
| US10945955B2 (en) | 2018-04-25 | 2021-03-16 | University Of Massachusetts | Artificial exosome composition and related methods |
| JPWO2019220759A1 (en) * | 2018-05-17 | 2021-07-15 | Ｓｔｅｍｃｅｌｌ株式会社 | Cancer analysis methods, cancer analysis systems, programs and computer-readable recording media |
| KR102180117B1 (en) * | 2018-06-14 | 2020-11-17 | 가톨릭대학교 산학협력단 | Hcc specific biomarkers |
| CN108949973B (en) * | 2018-06-21 | 2019-10-11 | 南京市妇幼保健院 | Biomarkers of Abnormal Trophoblast Invasion and Its Application |
| JP2021156577A (en) * | 2018-06-27 | 2021-10-07 | 国立大学法人大阪大学 | Obstructive lung disease biomarker |
| EP4344739A3 (en) * | 2018-06-29 | 2024-05-29 | North Carolina State University | Therapeutic lung repair by inhalation of lung spheroid cell-secreted factors |
| WO2020010311A2 (en) * | 2018-07-05 | 2020-01-09 | Active Genomes Expressed Diagnostics, Inc | Viral oncogene influences and gene expression patterns as indicators of early tumorigenesis |
| CN109061178B (en) * | 2018-07-05 | 2021-04-27 | 天津渤海水产研究所 | ELISA method for identifying cynoglossus semilaevis semen source exosomes |
| EP3820483A4 (en) | 2018-07-13 | 2023-03-01 | Yale University | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ENDOMETRIOSIS |
| CN108796070B (en) * | 2018-07-16 | 2022-09-30 | 辽宁中医药大学 | Application of miR-125a-3p in preparation of cardiovascular disease diagnosis kit |
| WO2020018926A1 (en) * | 2018-07-19 | 2020-01-23 | Intrexon Corporation | Exosome delivery of skin care peptides |
| KR102211972B1 (en) * | 2018-08-02 | 2021-02-04 | 엑소젠 피티이. 엘티디 | Method for early diagnosis of breast cancer and monitoring after treatment using liquid biopsy multi-cancer gene biomarkers |
| CN110824156B (en) * | 2018-08-14 | 2023-08-11 | 欧蒙医学诊断（中国）有限公司 | Diagnosis of neuroautoimmune disease |
| JP7577647B2 (en) * | 2018-08-31 | 2024-11-05 | エフ． ホフマン－ラ ロシュ アーゲー | Thymidine kinase (TK-1) in prognostic indicators for DLBCL |
| JP6677284B2 (en) * | 2018-10-09 | 2020-04-08 | 凸版印刷株式会社 | Analyte detection method and lateral flow test strip |
| AU2019362006A1 (en) * | 2018-10-17 | 2021-05-20 | ImMutriX Therapeutics, Inc. | Adsorption and binding of plasma molecules and particles to carbon |
| WO2020081859A1 (en) * | 2018-10-18 | 2020-04-23 | Nantbio, Inc. | Mesenchymal stem cell derived exosomes and methods |
| US11315660B2 (en) * | 2018-10-31 | 2022-04-26 | Dot Laboratories, Inc. | Method of detecting and treating endometriosis in a female subject |
| CN109507426B (en) * | 2018-11-29 | 2022-03-15 | 上海晟燃生物科技有限公司 | Prostate cancer diagnosis, grading or prognosis marker, detection reagent or kit, system and application thereof |
| CN109598709B (en) * | 2018-11-29 | 2023-05-26 | 东北大学 | Mammary gland auxiliary diagnosis system and method based on fusion depth characteristic |
| AU2019389175B2 (en) | 2018-11-30 | 2025-03-06 | Caris Mpi, Inc. | Next-generation molecular profiling |
| CN109557311B (en) * | 2018-12-13 | 2022-02-15 | 中南大学湘雅医院 | Colorectal cancer diagnosis marker, colorectal cancer detection product and application thereof |
| US12449424B2 (en) | 2018-12-14 | 2025-10-21 | Evonik Operations Gmbh | In vitro method for detecting avian intestinal dysbiosis |
| EP3908262A4 (en) | 2019-01-09 | 2022-12-28 | Exocure Biosciences, Inc. | VESICLES DERIVED FROM BACTERIA AND THEIR USES |
| CN109628277B (en) * | 2019-01-23 | 2022-02-01 | 东南大学 | System and method for separating and detecting tumor marker miRNA in exosome |
| CN113631725A (en) * | 2019-02-08 | 2021-11-09 | 得克萨斯州大学系统董事会 | Isolation and detection of exosome-associated microbiome for diagnostic and therapeutic purposes |
| CN109701038B (en) * | 2019-02-22 | 2021-02-23 | 上海大学 | Brain targeting exosome, preparation method and application thereof |
| US20220146500A1 (en) * | 2019-02-27 | 2022-05-12 | Yale University | Compositions and methods for enhancing mucosal immunity |
| US20220127681A1 (en) * | 2019-02-28 | 2022-04-28 | The Trustees Of Columbia University In The City Of New York | Sorting cell-type specific extracellular vesicles |
| US20220163532A1 (en) * | 2019-03-27 | 2022-05-26 | Board Of Regents, The University Of Texas System | Nuclear-derived exosomes and methods of use thereof |
| CA3135587A1 (en) * | 2019-04-05 | 2020-10-08 | Arizona Board Of Regents On Behalf Of Arizona State University | Diagnostic for maternal risk of having a child with autism spectrum disorder |
| WO2020231702A1 (en) * | 2019-05-11 | 2020-11-19 | Youngsuk Yi | Compositions and methods containing exosomes |
| CN110184357A (en) * | 2019-06-13 | 2019-08-30 | 徐州医科大学 | Prognosis prediction diagnosis gene marker of colon cancer and application thereof |
| CN110200986A (en) * | 2019-07-05 | 2019-09-06 | 深圳市康宁医院(深圳市精神卫生研究所深圳市精神卫生中心) | MiR-132 is preparing the application in the drug for treating habituation |
| CN110438053B (en) * | 2019-07-23 | 2022-03-11 | 天津大学 | A kind of biological storage system, construction method and application suitable for Synechococcus |
| JP6865800B2 (en) * | 2019-09-30 | 2021-04-28 | 勲 岡▲崎▼ | Breast cancer evaluation method and urinalysis kit for breast cancer evaluation |
| US20240319195A1 (en) * | 2019-10-15 | 2024-09-26 | Cornell University | Methods for detecting and inhibiting brain metastasis |
| JP6822537B2 (en) * | 2019-10-23 | 2021-01-27 | 株式会社Ｊｖｃケンウッド | How to detect exosomes |
| WO2021107154A1 (en) * | 2019-11-29 | 2021-06-03 | 富士フイルム和光純薬株式会社 | Method for assisting with diagnosis of alzheimer's disease or mild cognitive impairment, biomarker, reagent kit, and device |
| EP4069865A4 (en) | 2019-12-02 | 2023-12-20 | Caris MPI, Inc. | Pan-cancer platinum response predictor |
| CN110938687B (en) * | 2019-12-26 | 2023-06-27 | 广州医科大学附属第三医院（广州重症孕产妇救治中心、广州柔济医院） | Placenta-implanted disease marker |
| EP4083070B1 (en) * | 2019-12-27 | 2025-07-30 | The University of Osaka | Method for collecting extracellular vesicles derived from nervous system cells |
| CN111208297A (en) * | 2020-01-07 | 2020-05-29 | 何凤屏 | Method for detecting exosome GPC1 protein by using microfluidic chip and application of exosome GPC1 protein in early diagnosis of pancreatic cancer |
| US12091716B2 (en) | 2020-01-15 | 2024-09-17 | Mayo Foundation For Medical Education And Research | Methods and materials for identifying and treating traumatic brain injury |
| CN111239389A (en) * | 2020-01-20 | 2020-06-05 | 复旦大学附属中山医院 | Autoantibody marker for distinguishing liver cell liver cancer from normal person and screening method thereof |
| WO2021163416A1 (en) * | 2020-02-12 | 2021-08-19 | President And Fellows Of Harvard College | Methods of measuring and purifying extracellular vesicles |
| JPWO2021162114A1 (en) * | 2020-02-14 | 2021-08-19 | ||
| KR102316507B1 (en) * | 2020-02-28 | 2021-10-22 | 차의과학대학교 산학협력단 | Biomarker for Ovarian reserve and use thereof |
| CN111366525B (en) * | 2020-03-12 | 2021-08-13 | 西安交通大学 | A method and application for rapid detection of SARS-CoV-2 virus infection in isolated blood samples |
| AU2021255132A1 (en) | 2020-04-13 | 2022-12-08 | Exoprother Medical Ltd. | Cell-derived vesicles comprising wild-type P53 protein for antiviral therapy |
| US20210322483A1 (en) | 2020-04-16 | 2021-10-21 | Ichilov Tech Ltd. | Cell-derived particles presenting heterologous cd24 and use thereof in therapy |
| WO2021209622A1 (en) * | 2020-04-17 | 2021-10-21 | Therawis Diagnostics Gmbh | Method for enriching exosomes |
| US12392776B2 (en) * | 2020-06-01 | 2025-08-19 | City University Of Hong Kong | Methods and kits for detecting exosomal protein |
| AU2021305652A1 (en) * | 2020-07-08 | 2023-02-23 | Mercy Bioanalytics, Inc. | Compositions and methods for detection of lung cancer |
| CN111965366B (en) * | 2020-07-09 | 2022-11-29 | 何凤屏 | Method and kit for rapidly detecting exosome troponin by saliva |
| WO2022019583A1 (en) * | 2020-07-23 | 2022-01-27 | (주)메디톡스 | Therapeutic agent for exosome-mediated disease |
| WO2022029492A1 (en) * | 2020-08-06 | 2022-02-10 | Agendia NV | Methods of assessing breast cancer using machine learning systems |
| US20220042108A1 (en) * | 2020-08-06 | 2022-02-10 | Agendia NV | Systems and methods of assessing breast cancer |
| EP4200048A1 (en) * | 2020-08-18 | 2023-06-28 | Sartorius BIA Separations d.o.o. | Metal-affinity extraction of host cell dna |
| WO2022046655A1 (en) * | 2020-08-24 | 2022-03-03 | Fluorome, Inc. | Methods and compositions for exosome-based diagnostics and diagnosis of disease |
| IL277743A (en) | 2020-10-01 | 2022-04-01 | Yeda Res & Dev | Method of diagnosing breast cancer |
| CN114544826B (en) * | 2020-11-24 | 2023-12-08 | 重庆医科大学 | Use of reagents for detecting histidine in plasma in preparing depression detection kits |
| KR20220076406A (en) * | 2020-11-30 | 2022-06-08 | 피씨엘 (주) | Novel biomarker for diagnosing Alzheimer's disease derived from blood's exosome and method for diagnosing Alzheimer's disease using the same |
| US20220205992A1 (en) * | 2020-12-28 | 2022-06-30 | Quanterix Corporation | Materials and kits relating to association of reporter species and targeting entities with beads |
| CN113177574B (en) * | 2021-03-19 | 2022-08-16 | 华中科技大学 | Visual model for material characterization image analysis and analysis method thereof |
| US20240192213A1 (en) * | 2021-04-20 | 2024-06-13 | The Administrators Of The Tulane Educational Fund | Method of detecting disease related biomarkers in bodily fluid sample |
| JP7661767B2 (en) * | 2021-04-28 | 2025-04-15 | 東ソー株式会社 | Methods for detecting extracellular vesicles |
| CN113504369B (en) * | 2021-06-23 | 2024-07-05 | 阳普医疗科技股份有限公司 | Individuation correction formula for eliminating positive interference of serum nerve-specific enolase detection caused by sample hemolysis and application thereof |
| WO2023283410A2 (en) * | 2021-07-09 | 2023-01-12 | Board Of Regents, The University Of Texas System | Exosomal lipids and metabolites for the early detection of hepatocellular carcinoma |
| WO2023004080A2 (en) * | 2021-07-21 | 2023-01-26 | Mercy Bioanalytics, Inc. | Compositions and methods for detection of pancreatic cancer |
| WO2023004082A1 (en) * | 2021-07-21 | 2023-01-26 | Mercy Bioanalytics, Inc. | Compositions and methods for detection of prostate cancer |
| CN114047331A (en) * | 2021-09-22 | 2022-02-15 | 西安交通大学医学院第一附属医院 | A marker for allergic purpura and its application |
| CN115902231A (en) * | 2021-09-23 | 2023-04-04 | 上海思路迪生物医学科技有限公司 | Antibody detection solution and exosome detection kit for chemiluminescence immunoassay |
| CN114371135B (en) * | 2021-10-25 | 2024-01-30 | 孙良丹 | Evaluation system for evaluating psoriasis and application |
| US20230147720A1 (en) * | 2021-11-05 | 2023-05-11 | Spiritus Therapeutics, Inc. | Purified Enriched Population Exosomes Derived From Individuals With A Chronic Progressive Lung Disease For Noninvasive Detection, Staging, And Medical Monitoring Of Disease Progression |
| WO2023112482A1 (en) * | 2021-12-14 | 2023-06-22 | シスメックス株式会社 | Method for measuring extracellular vesicles, method for acquiring information on neurodegeneration, method for isolating extracellular vesicles and reagent kits |
| CN113960313B (en) * | 2021-12-22 | 2022-04-12 | 上海思路迪医学检验所有限公司 | Exosome ALK fusion protein magnetic immunochemiluminescence detection kit |
| CN114592048A (en) * | 2022-03-10 | 2022-06-07 | 天津大学温州安全(应急)研究院 | Method for predicting coagulation dysfunction of recurrent abortion population in pregnancy |
| WO2023182508A1 (en) * | 2022-03-25 | 2023-09-28 | 学校法人国際医療福祉大学 | Method for verifying disease using extracellular vesicle surface molecules, and verification kit |
| WO2023196586A1 (en) * | 2022-04-07 | 2023-10-12 | The Regents Of The University Of Michigan | Methods and devices for screening extracellular vesicles |
| CN114984047B (en) * | 2022-04-29 | 2023-10-03 | 山东克洛伊美生物医药科技有限公司 | Application of plasma exosome in preparation of medicine for treating osteoporosis |
| CN114783609B (en) * | 2022-05-11 | 2025-07-15 | 深圳市人民医院 | A prognostic scoring system for hepatocellular carcinoma based on PUS family genes and its application |
| CN114990159A (en) * | 2022-05-18 | 2022-09-02 | 昆明理工大学 | A kind of establishment method of micorRNA206 inhibiting HCV proliferation |
| CN115097143B (en) * | 2022-07-11 | 2023-07-21 | 东南大学 | Application of vitamin D binding protein in peripheral blood plasma total exosomes in the diagnosis of depression |
| CN115166260B (en) * | 2022-07-11 | 2023-06-13 | 东南大学 | Application of vitamin D binding protein in exosome derived from blood plasma brain cells in diagnosis of depression |
| CN116271107B (en) * | 2022-11-30 | 2025-05-13 | 上海交通大学医学院附属仁济医院 | Endogenous nano probe, preparation method and application thereof |
| CN116585493A (en) * | 2022-12-27 | 2023-08-15 | 华中科技大学同济医学院附属协和医院 | Application of PRDM16 gene overexpression reagent in preparation of drugs for preventing or treating chronic kidney disease |
| WO2024158609A1 (en) * | 2023-01-23 | 2024-08-02 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Hyper-throughput, multiplex, single molecule imaging platform |
| WO2024243152A2 (en) * | 2023-05-19 | 2024-11-28 | The Cleveland Clinic Foundation | Human eif3l binding molecules and cancer exosome diagnostics and anti-thrombotic treatment |
| CN117024557B (en) * | 2023-10-10 | 2024-01-30 | 天津外泌体科技有限公司 | Application of 14-3-3 protein theta isomer as extracellular vesicle scaffold protein and extracellular vesicle |
| WO2025090771A1 (en) * | 2023-10-27 | 2025-05-01 | Yale University | Immune cell microvesicle profiling for surveillance and treatment of donor transplant rejection |
Family Cites Families (307)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US637619A (en) | 1897-02-08 | 1899-11-21 | Lucian A Kimball | Self-reefing sail for canoes, &c. |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4551435A (en) | 1983-08-24 | 1985-11-05 | Immunicon, Inc. | Selective removal of immunospecifically recognizable substances from solution |
| US4725550A (en) | 1984-01-19 | 1988-02-16 | Research Foundation Of State University Of New York | Novel mutation of the c-K-ras oncogene activated in a human lung carcinoma |
| IL72452A (en) | 1984-07-19 | 1988-04-29 | Channa Shalitin | Method for the preparation of yeast chromatin and separating p20 polypeptide thereof |
| US4737456A (en) | 1985-05-09 | 1988-04-12 | Syntex (U.S.A.) Inc. | Reducing interference in ligand-receptor binding assays |
| US4795698A (en) | 1985-10-04 | 1989-01-03 | Immunicon Corporation | Magnetic-polymer particles |
| US4925788A (en) | 1986-10-24 | 1990-05-15 | Immunicon Corporation | Immunoassay system and procedure based on precipitin-like interaction between immune complex and Clq or other non-immunospecific factor |
| US5089181A (en) * | 1987-02-24 | 1992-02-18 | Vestar, Inc. | Method of dehydrating vesicle preparations for long term storage |
| US5158871A (en) | 1988-02-12 | 1992-10-27 | University Of Connecticut | Method of using magnetic particles for isolating, collecting and assaying diagnostic ligates |
| US4957859A (en) | 1988-02-16 | 1990-09-18 | Hoffmann-La Roche Inc. | Antibodies for transforming ras protein |
| US5700637A (en) | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
| US6117674A (en) | 1988-06-30 | 2000-09-12 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Pathogen propagation in cultured three-dimensional tissue mass |
| US5026650A (en) | 1988-06-30 | 1991-06-25 | The United States Of Amercia As Represented By The Administrator Of The National Aeronautics And Space Administration | Horizontally rotated cell culture system with a coaxial tubular oxygenator |
| US5153131A (en) | 1990-12-11 | 1992-10-06 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | High aspect reactor vessel and method of use |
| US5108933A (en) | 1988-09-16 | 1992-04-28 | Immunicon Corporation | Manipulation of colloids for facilitating magnetic separations |
| GB8822228D0 (en) | 1988-09-21 | 1988-10-26 | Southern E M | Support-bound oligonucleotides |
| US5527681A (en) | 1989-06-07 | 1996-06-18 | Affymax Technologies N.V. | Immobilized molecular synthesis of systematically substituted compounds |
| US5242974A (en) | 1991-11-22 | 1993-09-07 | Affymax Technologies N.V. | Polymer reversal on solid surfaces |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
| DE3924454A1 (en) | 1989-07-24 | 1991-02-07 | Cornelis P Prof Dr Hollenberg | THE APPLICATION OF DNA AND DNA TECHNOLOGY FOR THE CONSTRUCTION OF NETWORKS FOR USE IN CHIP CONSTRUCTION AND CHIP PRODUCTION (DNA CHIPS) |
| US5104802A (en) | 1989-07-28 | 1992-04-14 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Hollow fiber clinostat for simulating microgravity in cell culture |
| US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| US5200084A (en) | 1990-09-26 | 1993-04-06 | Immunicon Corporation | Apparatus and methods for magnetic separation |
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US5186827A (en) | 1991-03-25 | 1993-02-16 | Immunicon Corporation | Apparatus for magnetic separation featuring external magnetic means |
| US6221620B1 (en) | 1991-04-24 | 2001-04-24 | The United States Of America As Represented By The Department Of Health And Human Services | Monoclonal antibodies specific for human thymidylate synthase |
| IL103674A0 (en) | 1991-11-19 | 1993-04-04 | Houston Advanced Res Center | Method and apparatus for molecule detection |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| US5412087A (en) | 1992-04-24 | 1995-05-02 | Affymax Technologies N.V. | Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces |
| WO1993022456A1 (en) | 1992-04-27 | 1993-11-11 | Trustees Of Dartmouth College | Detection of gene sequences in biological fluids |
| US5554501A (en) | 1992-10-29 | 1996-09-10 | Beckman Instruments, Inc. | Biopolymer synthesis using surface activated biaxially oriented polypropylene |
| US5702941A (en) | 1993-09-09 | 1997-12-30 | Synthecon, Inc. | Gas permeable bioreactor and method of use |
| US5437998A (en) | 1993-09-09 | 1995-08-01 | Synthecon, Inc. | Gas permeable bioreactor and method of use |
| US5472672A (en) | 1993-10-22 | 1995-12-05 | The Board Of Trustees Of The Leland Stanford Junior University | Apparatus and method for polymer synthesis using arrays |
| US5429807A (en) | 1993-10-28 | 1995-07-04 | Beckman Instruments, Inc. | Method and apparatus for creating biopolymer arrays on a solid support surface |
| US5538848A (en) | 1994-11-16 | 1996-07-23 | Applied Biosystems Division, Perkin-Elmer Corp. | Method for detecting nucleic acid amplification using self-quenching fluorescence probe |
| US5610281A (en) | 1994-05-03 | 1997-03-11 | Brigham & Women's Hospital, Inc. | Antibodies for modulating heterotypic E-cadherin interactions with human T lymphocytes |
| US5571639A (en) | 1994-05-24 | 1996-11-05 | Affymax Technologies N.V. | Computer-aided engineering system for design of sequence arrays and lithographic masks |
| US5753441A (en) | 1994-08-12 | 1998-05-19 | Myriad Genetics, Inc. | 170-linked breast and ovarian cancer susceptibility gene |
| US5710001A (en) | 1994-08-12 | 1998-01-20 | Myriad Genetics, Inc. | 17q-linked breast and ovarian cancer susceptibility gene |
| MX9701075A (en) | 1994-08-12 | 1998-03-31 | Myriad Genetics Inc | LIVE MUTATIONS AND POLYMORPHISMS IN THE GENE OF SUSCEPTIBILITY TO BREAST CANCER AND OVARY LINKED WITH 17Q. |
| US5747282A (en) | 1994-08-12 | 1998-05-05 | Myraid Genetics, Inc. | 17Q-linked breast and ovarian cancer susceptibility gene |
| US5693473A (en) | 1994-08-12 | 1997-12-02 | Myriad Genetics, Inc. | Linked breast and ovarian cancer susceptibility gene |
| WO1996005308A1 (en) | 1994-08-12 | 1996-02-22 | Myriad Genetics, Inc. | Method for diagnosing a predisposition for breast and ovarian cancer |
| US5556752A (en) | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
| GB9422814D0 (en) | 1994-11-11 | 1995-01-04 | Medinnova Sf | Chemical method |
| US5599695A (en) | 1995-02-27 | 1997-02-04 | Affymetrix, Inc. | Printing molecular library arrays using deprotection agents solely in the vapor phase |
| US5624711A (en) | 1995-04-27 | 1997-04-29 | Affymax Technologies, N.V. | Derivatization of solid supports and methods for oligomer synthesis |
| US5545531A (en) | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
| US5523228A (en) | 1995-07-07 | 1996-06-04 | Hmri/Clmf | Hydrodynamic cell culture environment for three dimensional tissue growth |
| US5658734A (en) | 1995-10-17 | 1997-08-19 | International Business Machines Corporation | Process for synthesizing chemical compounds |
| NO954667D0 (en) | 1995-11-17 | 1995-11-17 | Dagfinn Oegreid | Method for detecting Ki-ras mutations |
| US5998151A (en) | 1995-12-01 | 1999-12-07 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for predicting the efficacy of a chemotherapeutic regimen for gastrointestinal cancers using antibodies specific for thymidylate synthase |
| NZ326525A (en) | 1995-12-18 | 1999-11-29 | Endorecherche Inc | Chromosome 13-linked breast cancer susceptibility gene |
| US5837492A (en) | 1995-12-18 | 1998-11-17 | Myriad Genetics, Inc. | Chromosome 13-linked breast cancer susceptibility gene |
| WO1997035589A1 (en) | 1996-03-26 | 1997-10-02 | Kopreski Michael S | Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer |
| US5895748A (en) | 1996-11-27 | 1999-04-20 | Johnson; Keith R. | Panel of antibodies for detecting cadherins and catenins in tissues and method of using the panel of antibodies |
| US6262242B1 (en) | 1997-01-30 | 2001-07-17 | Board Of Regents, The University Of Texas System | Tumor suppressor designated TS10Q23.3 |
| US6482795B1 (en) | 1997-01-30 | 2002-11-19 | Myriad Genetics, Inc. | Tumor suppressor designated TS10q23.3 |
| WO1998033518A1 (en) | 1997-02-04 | 1998-08-06 | Sloan-Kettering Institute For Cancer Research | Mutants of thymidylate synthase and uses thereof |
| US6150514A (en) | 1997-04-09 | 2000-11-21 | University Of Utah Research Foundation | 14 Kilobase deletion in the promoter region of BRCA1 in a breast cancer family |
| FR2766205B1 (en) | 1997-07-16 | 2002-08-30 | Inst Nat Sante Rech Med | NOVEL METHOD FOR SENSITIZING ANTIGEN PRESENTING CELLS AND NOVEL MEANS FOR IMPLEMENTING THE METHOD |
| GB9715034D0 (en) | 1997-07-18 | 1997-09-24 | Zeneca Ltd | Assay |
| US6218114B1 (en) | 1998-03-27 | 2001-04-17 | Academia Sinica | Methods for detecting differentially expressed genes |
| US6004755A (en) | 1998-04-07 | 1999-12-21 | Incyte Pharmaceuticals, Inc. | Quantitative microarray hybridizaton assays |
| US6218122B1 (en) | 1998-06-19 | 2001-04-17 | Rosetta Inpharmatics, Inc. | Methods of monitoring disease states and therapies using gene expression profiles |
| US6406921B1 (en) | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
| DE19833738A1 (en) | 1998-07-27 | 2000-02-03 | Michael Giesing | Process for isolating cancer cells from cell-containing body fluids and kits for performing this process |
| WO2000024940A1 (en) | 1998-10-28 | 2000-05-04 | Vysis, Inc. | Cellular arrays and methods of detecting and using genetic disorder markers |
| CA2356286C (en) | 1998-12-23 | 2010-12-21 | University Of Sydney | An assay to detect a binding partner |
| FR2788780B1 (en) | 1999-01-27 | 2001-03-30 | Ap Cells Inc | PROCESS FOR THE PREPARATION OF MEMBRANE VESICLES |
| JP4523169B2 (en) | 1999-02-04 | 2010-08-11 | プルリステム リミテッド | Method and apparatus for maintaining and increasing hematopoietic stem cells and / or progenitor cells |
| US6811668B1 (en) | 1999-06-22 | 2004-11-02 | Caliper Life Sciences, Inc. | Apparatus for the operation of a microfluidic device |
| AUPQ147799A0 (en) | 1999-07-07 | 1999-07-29 | Medvet Science Pty. Ltd. | Mesenchymal precursor cell |
| US6586177B1 (en) | 1999-09-08 | 2003-07-01 | Exact Sciences Corporation | Methods for disease detection |
| US6271002B1 (en) | 1999-10-04 | 2001-08-07 | Rosetta Inpharmatics, Inc. | RNA amplification method |
| JP3875436B2 (en) | 1999-10-28 | 2007-01-31 | 富士通株式会社 | Network management apparatus and recording medium |
| GB9927320D0 (en) * | 1999-11-18 | 2000-01-12 | Chiron Spa | Exosome separation |
| AU2001232805A1 (en) | 2000-01-12 | 2001-07-24 | Ut-Battelle, Llc | A microfluidic device and method for focusing, segmenting, and dispensing of a fluid stream |
| US7452713B2 (en) | 2000-02-29 | 2008-11-18 | Stmicroelectronics S.R.L. | Process for manufacturing a microfluidic device with buried channels |
| US20040170977A1 (en) | 2000-03-31 | 2004-09-02 | Peter Laird | Epigenetic sequences for esophageal adenocarcinoma |
| US6812023B1 (en) | 2000-04-27 | 2004-11-02 | Anosys, Inc. | Methods of producing membrane vesicles |
| US20040241176A1 (en) | 2000-04-27 | 2004-12-02 | Ap Cells. Inc. | Method of producing membrane vesicles |
| EP1158055A1 (en) | 2000-05-26 | 2001-11-28 | Xu Qi University of Teaxs Laboratoire de Leucémie Chen | Method for diagnosing cancers |
| US6649359B2 (en) | 2000-06-01 | 2003-11-18 | The Brigham & Women's Hospital, Inc. | Diagnosis of endometrial precancers |
| EP1340082A2 (en) | 2000-08-23 | 2003-09-03 | Imego AB | Microfluidic device and method with transport of magnetic particles into and out of wells |
| US20020048534A1 (en) | 2000-08-24 | 2002-04-25 | David Storek | Sample preparing arrangement and a method relating to such an arrangement |
| US6822454B2 (en) | 2000-12-01 | 2004-11-23 | Protasis Corporation | Microfluidic device with multiple microcoil NMR detectors and field gradient focusing |
| US20020142328A1 (en) | 2000-12-01 | 2002-10-03 | Danenberg Kathleen D. | Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors |
| US7049059B2 (en) | 2000-12-01 | 2006-05-23 | Response Genetics, Inc. | Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression |
| GB0031566D0 (en) | 2000-12-22 | 2001-02-07 | Mets Ometrix | Methods for spectral analysis and their applications |
| US20020150966A1 (en) | 2001-02-09 | 2002-10-17 | Muraca Patrick J. | Specimen-linked database |
| US7323140B2 (en) | 2001-03-28 | 2008-01-29 | Handylab, Inc. | Moving microdroplets in a microfluidic device |
| US20030036077A1 (en) * | 2001-05-31 | 2003-02-20 | Chronix Biomedical | Methods for generating an mRNA expression profile from an ecellular mRNA containing blood sample and using the same to identify functional state markers |
| WO2002099077A2 (en) * | 2001-06-06 | 2002-12-12 | Proteologics, Inc. | Methods and compositions related to tagging of membrane surface proteins |
| EP1417229B1 (en) | 2001-08-17 | 2011-06-15 | Exothera L.L.C. | Methods and compounds for the targeting of protein to exosomes |
| US7390463B2 (en) | 2001-09-07 | 2008-06-24 | Corning Incorporated | Microcolumn-based, high-throughput microfluidic device |
| DE60237289D1 (en) | 2001-09-17 | 2010-09-23 | Gyros Patent Ab | A CONTROLLED POWER IN A MICROFLUID DEVICE ENABLING FUNCTION UNIT |
| US7253003B2 (en) | 2001-10-19 | 2007-08-07 | Wisconsin Alumni Research Foundation | Method for monitoring the environment within a microfluidic device |
| US7189580B2 (en) | 2001-10-19 | 2007-03-13 | Wisconsin Alumni Research Foundation | Method of pumping fluid through a microfluidic device |
| WO2003054774A1 (en) | 2001-11-02 | 2003-07-03 | Gene Network Sciences, Inc. | Language for networks |
| US7415359B2 (en) | 2001-11-02 | 2008-08-19 | Gene Network Sciences, Inc. | Methods and systems for the identification of components of mammalian biochemical networks as targets for therapeutic agents |
| US20070203333A1 (en) | 2001-11-30 | 2007-08-30 | Mcswiggen James | RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) |
| JP4355210B2 (en) | 2001-11-30 | 2009-10-28 | フルイディグム コーポレイション | Microfluidic device and method of using microfluidic device |
| AU2002360499A1 (en) | 2001-12-05 | 2003-06-17 | University Of Washington | Microfluidic device and surface decoration process for solid phase affinity binding assays |
| US7238255B2 (en) | 2001-12-31 | 2007-07-03 | Gyros Patent Ab | Microfluidic device and its manufacture |
| AU2003217700A1 (en) | 2002-02-26 | 2003-09-09 | Stelsys Llc | Hepatocyte bioreactor system for long term culture of functional hepatocyte spheroids |
| US6958119B2 (en) | 2002-02-26 | 2005-10-25 | Agilent Technologies, Inc. | Mobile phase gradient generation microfluidic device |
| JP3481231B2 (en) | 2002-03-05 | 2003-12-22 | 三洋電機株式会社 | Organic electroluminescent display device and method of manufacturing the same |
| US7195986B1 (en) | 2002-03-08 | 2007-03-27 | Caliper Life Sciences, Inc. | Microfluidic device with controlled substrate conductivity |
| DK2261369T3 (en) | 2002-03-13 | 2014-07-28 | Genomic Health Inc | Gene expression profiling in tumor tissue biopsies |
| US20030194734A1 (en) | 2002-03-29 | 2003-10-16 | Tim Jatkoe | Selection of markers |
| US7189581B2 (en) | 2002-04-30 | 2007-03-13 | Wisconsin Alumni Research Foundation | Method of obtaining a sample concentration of a solution in a microfluidic device |
| DE60228685D1 (en) | 2002-05-16 | 2008-10-16 | Micronit Microfluidics Bv | Method for producing a microfluidic component |
| US7560239B2 (en) * | 2002-06-04 | 2009-07-14 | Lin-Zhi International Inc. | Homogeneous enzyme immunoassay for simultaneous detection of multiple analytes |
| AU2003253629A1 (en) | 2002-06-07 | 2003-12-22 | Myriad Genetics, Inc | Large deletions in human brca1 gene and use thereof |
| WO2004007582A2 (en) | 2002-07-15 | 2004-01-22 | University Of Virginia Patent Foundation | Hybrid polymers for functional tuning of microfluidic device surfaces |
| US7201881B2 (en) | 2002-07-26 | 2007-04-10 | Applera Corporation | Actuator for deformable valves in a microfluidic device, and method |
| US7452509B2 (en) | 2002-07-26 | 2008-11-18 | Applied Biosystems Inc. | Microfluidic device including displaceable material trap, and system |
| US7135147B2 (en) | 2002-07-26 | 2006-11-14 | Applera Corporation | Closing blade for deformable valve in a microfluidic device and method |
| ES2215957T3 (en) | 2002-08-01 | 2004-10-16 | Mtm Laboratories Ag | METHOD FOR DIAGNOSIS BASED ON A SOLUTION. |
| KR100480338B1 (en) | 2002-08-08 | 2005-03-30 | 한국전자통신연구원 | Microfluidic devices for the controlled movements of solution |
| AT500648B1 (en) * | 2002-08-12 | 2010-03-15 | Igeneon Krebs Immuntherapie | SET FOR THE TREATMENT OF CANCER PATIENTS |
| DE60321689D1 (en) | 2002-08-29 | 2008-07-31 | Gene Network Sciences Inc | SYSTEMS AND METHOD FOR CLOSING BIOLOGICAL NETWORKS |
| TW536524B (en) | 2002-09-17 | 2003-06-11 | Fan-Gen Tzeng | Network-type micro-channel device for micro-fluid |
| US7118661B2 (en) | 2002-09-30 | 2006-10-10 | The Regents Of The University Of California | Nanolaminate microfluidic device for mobility selection of particles |
| EP1581612B1 (en) | 2002-10-04 | 2016-06-15 | Noo Li Jeon | Microfluidic multi-compartment device for neuroscience research |
| US20040088116A1 (en) | 2002-11-04 | 2004-05-06 | Gene Network Sciences, Inc. | Methods and systems for creating and using comprehensive and data-driven simulations of biological systems for pharmacological and industrial applications |
| CA2504605C (en) * | 2002-11-13 | 2016-01-19 | Thomas Jefferson University | Treatment of chronic lymphocytic leukemia and prostate cancer with microrna mir15 |
| US7906326B2 (en) | 2003-05-07 | 2011-03-15 | Rosetta Genomics Ltd. | Bioinformatically detectable group of novel regulatory oligonucleotides associated with alzheimer's disease and uses thereof |
| US7250496B2 (en) | 2002-11-14 | 2007-07-31 | Rosetta Genomics Ltd. | Bioinformatically detectable group of novel regulatory genes and uses thereof |
| FR2848125B1 (en) | 2002-12-04 | 2006-06-09 | Commissariat Energie Atomique | MICROFLUIDIC DEVICE IN WHICH THE LIQUID / FLUID INTERFACE IS STABILIZED |
| US7467928B2 (en) | 2002-12-12 | 2008-12-23 | Board Of Trustees Of The University Of Arkansas | Microfluidic device utilizing magnetohydrodynamics and method for fabrication thereof |
| US7125711B2 (en) | 2002-12-19 | 2006-10-24 | Bayer Healthcare Llc | Method and apparatus for splitting of specimens into multiple channels of a microfluidic device |
| RU2353399C2 (en) * | 2003-01-17 | 2009-04-27 | Этлон Медикал, Инк. | Method of isolating virus from blood by lectin hemodialysis |
| US7338637B2 (en) | 2003-01-31 | 2008-03-04 | Hewlett-Packard Development Company, L.P. | Microfluidic device with thin-film electronic devices |
| US7413709B2 (en) | 2003-02-12 | 2008-08-19 | Agilent Technologies, Inc. | PAEK-based microfluidic device with integrated electrospray emitter |
| US7914792B2 (en) | 2003-02-14 | 2011-03-29 | Exothera L.L.C. | Methods and compounds for raising antibodies and for screening antibody repertoires |
| EP1597391B1 (en) | 2003-02-20 | 2008-10-29 | Genomic Health, Inc. | Use of intronic rna to measure gene expression |
| JP3856763B2 (en) | 2003-03-11 | 2006-12-13 | 財団法人川村理化学研究所 | Manufacturing method of microfluidic device |
| MXPA05010778A (en) * | 2003-04-09 | 2005-12-12 | Genentech Inc | Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor. |
| US7361460B2 (en) | 2003-04-11 | 2008-04-22 | Digene Corporation | Approach to molecular diagnosis of human papillomavirus-related diseases |
| US20050084913A1 (en) * | 2003-04-22 | 2005-04-21 | Maxygen, Inc. | Novel tumor-associated antigens |
| US7267950B2 (en) | 2003-05-01 | 2007-09-11 | Veridex, Lcc | Rapid extraction of RNA from cells and tissues |
| US7422725B2 (en) | 2003-05-01 | 2008-09-09 | Enplas Corporation | Sample handling unit applicable to microchip, and microfluidic device having microchips |
| WO2004111273A2 (en) | 2003-05-30 | 2004-12-23 | Genomic Health, Inc. | Gene expression markers for response to egfr inhibitor drugs |
| JP4758891B2 (en) | 2003-06-06 | 2011-08-31 | マイクロニクス， インコーポレイテッド | Systems and methods for heating, cooling and thermal cycling on microfluidic devices |
| US7319007B2 (en) | 2003-06-12 | 2008-01-15 | Pomeranian Academy Of Medicine | Determining a predisposition to cancer |
| US20050158718A1 (en) * | 2003-06-16 | 2005-07-21 | Taylor Michael D. | Diagnostic and therapeutic uses of SUFU gene |
| DK3170906T3 (en) | 2003-06-24 | 2018-11-05 | Genomic Health Inc | PREDICTION OF THE LIKELI REVENUE OF CANCER |
| DK1644858T3 (en) | 2003-07-10 | 2018-01-22 | Genomic Health Inc | Functional clothing with at least one outer layer and inner membrane. |
| US20050059024A1 (en) | 2003-07-25 | 2005-03-17 | Ambion, Inc. | Methods and compositions for isolating small RNA molecules |
| GB0318096D0 (en) | 2003-08-01 | 2003-09-03 | Queen Mary & Westfield College | Vaccine |
| US7888497B2 (en) | 2003-08-13 | 2011-02-15 | Rosetta Genomics Ltd. | Bioinformatically detectable group of novel regulatory oligonucleotides and uses thereof |
| PL1668152T3 (en) | 2003-08-28 | 2009-06-30 | Ipsogen | Identification of an erbb2 gene expression signature in breast cancer |
| EP1510577A1 (en) | 2003-08-29 | 2005-03-02 | Qiagen GmbH | Method for magnetic bead isolation of nucleic acids |
| US7981618B2 (en) | 2003-11-05 | 2011-07-19 | Board Of Regents Of The University Of Texas System | Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer |
| FR2862007B1 (en) | 2003-11-12 | 2005-12-23 | Commissariat Energie Atomique | MICROFLUIDIC DEVICE WITH AN ELECTRONEBULATING NOSE. |
| US7635586B2 (en) * | 2003-11-26 | 2009-12-22 | Broadley-James Corporation | Integrated bio-reactor monitor and control system |
| EP1538219A1 (en) | 2003-12-04 | 2005-06-08 | Erasmus University Medical Center Rotterdam | Method to diagnose or screen for type 1 diabetes mellitus |
| US7329391B2 (en) | 2003-12-08 | 2008-02-12 | Applera Corporation | Microfluidic device and material manipulating method using same |
| EP1547688A1 (en) | 2003-12-23 | 2005-06-29 | STMicroelectronics S.r.l. | Microfluidic device and method of locally concentrating electrically charged substances in a microfluidic device |
| US7099778B2 (en) | 2003-12-30 | 2006-08-29 | Caliper Life Sciences, Inc. | Method for determining diffusivity and molecular weight in a microfluidic device |
| CA2453198A1 (en) * | 2004-01-07 | 2005-07-07 | Wei-Ping Min | Quantification and generation of immune suppressive exosomes |
| US7351380B2 (en) | 2004-01-08 | 2008-04-01 | Sandia Corporation | Microfluidic structures and methods for integrating a functional component into a microfluidic device |
| US20050221398A1 (en) | 2004-01-16 | 2005-10-06 | Ipsogen, Sas, A Corporation Of France | Protein expression profiling and breast cancer prognosis |
| EP1711632A4 (en) | 2004-01-19 | 2009-03-11 | Technion Res & Dev Foundation | Diagnostic test for parkinson's disease |
| PL1720611T3 (en) | 2004-02-16 | 2010-09-30 | Proteosys Ag | Diagnostic marker for cancer |
| US8426126B2 (en) | 2004-03-18 | 2013-04-23 | Applied Biosystems, Llc | Modified surfaces as solid supports for nucleic acid purification |
| WO2005092038A2 (en) | 2004-03-22 | 2005-10-06 | The Johns Hopkins University | Methods for the detection of nucleic acid differences |
| US7402229B2 (en) | 2004-03-31 | 2008-07-22 | Intel Corporation | Fabrication and use of semipermeable membranes and gels for the control of electrolysis in a microfluidic device |
| WO2005097667A2 (en) | 2004-04-02 | 2005-10-20 | Eksigent Technologies Llc | Microfluidic device |
| CA2848463A1 (en) | 2004-04-09 | 2005-10-27 | Genomic Health, Inc. | Gene expression markers for predicting response to chemotherapy |
| US7419639B2 (en) | 2004-05-12 | 2008-09-02 | The Board Of Trustees Of The Leland Stanford Junior University | Multilayer microfluidic device |
| CA2566662C (en) * | 2004-05-13 | 2013-05-07 | Centre National De La Recherche Scientifique | A device for binding a target entity to a bait entity and detection methods using the same |
| WO2005121369A2 (en) | 2004-06-02 | 2005-12-22 | Sourcepharm, Inc. | Rna-containing microvesicles and methods therefor |
| US8021847B2 (en) | 2004-06-02 | 2011-09-20 | Proxy Life Science Holdings, Inc. | Microvesicle-based compositions and methods |
| BRPI0510645A (en) | 2004-06-04 | 2007-11-20 | Veridex Llc | diagnosis or prognosis of breast cancer progress, composition comprising nucleic acid primer / probe sets and intraoperative lymph node analysis kit |
| US20050277121A1 (en) | 2004-06-11 | 2005-12-15 | Ambion, Inc. | Crude biological derivatives competent for nucleic acid detection |
| WO2006004910A2 (en) | 2004-06-28 | 2006-01-12 | Transtarget Inc. | Improved bispecific antibodies |
| JP2008505104A (en) * | 2004-07-01 | 2008-02-21 | ユニヴァーシティ オヴ ピッツバーグ オヴ ザ コモンウェルス システム オヴ ハイアー エデュケーション | Immunosuppressive exosomes |
| US8048418B2 (en) | 2004-10-29 | 2011-11-01 | Regeneron Pharmaceuticals, Inc. | Therapeutic methods for inhibiting tumor growth with combination of Dll4 antagonists and VEGF antagonists |
| WO2006054991A1 (en) | 2004-11-17 | 2006-05-26 | Immunivest Corporation | Magnetic enrichment of circulating cells, fragments and debris for enabling hts proteomics and genomics in disease detection |
| US7488596B2 (en) | 2004-12-17 | 2009-02-10 | Samsung Electronics Co., Ltd. | Microfluidic device comprising electrolysis device for cell lysis and method for electrochemically lysing cells using the same |
| CA2491067A1 (en) * | 2004-12-24 | 2006-06-24 | Stichting Katholieke Universiteit | Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer |
| CN101107358A (en) * | 2005-01-25 | 2008-01-16 | 天空遗传学公司 | Nucleic acid for apoptosis of cancer cells |
| US8071306B2 (en) | 2005-01-25 | 2011-12-06 | Merck Sharp & Dohme Corp. | Methods for quantitating small RNA molecules |
| WO2006087233A2 (en) | 2005-02-21 | 2006-08-24 | Max-Planck-Gesellschaft zur Förderung der Wissenschaft e.V. | Release of extracellular membrane particles carrying the stem cell marker prominin-1 (cd133) from neural progenitors and other epithelial cells |
| US8349555B2 (en) | 2005-03-16 | 2013-01-08 | Gennadi V. Glinsky | Methods and compositions for predicting death from cancer and prostate cancer survival using gene expression signatures |
| WO2006102687A1 (en) * | 2005-03-22 | 2006-09-28 | The Trustees Of Columbia University In The City Of New York | A liposome-based microarray and methods of use thereof |
| AU2006240184A1 (en) | 2005-04-12 | 2006-11-02 | Caliper Life Sciences, Inc. | Compact optical detection system for a microfluidic devices |
| US20090061422A1 (en) | 2005-04-19 | 2009-03-05 | Linke Steven P | Diagnostic markers of breast cancer treatment and progression and methods of use thereof |
| US20060275844A1 (en) | 2005-04-19 | 2006-12-07 | Linke Steven P | Diagnostic markers of breast cancer treatment and progression and methods of use thereof |
| EP1722231A3 (en) | 2005-04-27 | 2009-03-11 | MPB MelTec Patent- und Beteiligungsgesellschaft mbH | Method for identification of somatic stem cells |
| US20090118175A1 (en) | 2005-05-06 | 2009-05-07 | Macina Roberto A | Compositions and Methods for Detection, Prognosis and Treatment of Breast Cancer |
| KR100590581B1 (en) | 2005-05-10 | 2006-06-19 | 삼성전자주식회사 | Microfluidic device and its manufacturing method |
| JP4992201B2 (en) | 2005-06-07 | 2012-08-08 | 富士ゼロックス株式会社 | Microfluidic control method, microfluidic device and manufacturing method thereof |
| SI1913157T2 (en) | 2005-06-28 | 2017-02-28 | Genentech, Inc. | Egfr and kras mutations for prediction of patient response to egfr inhibitor treatment |
| WO2007003344A2 (en) | 2005-06-30 | 2007-01-11 | Biocrates Life Sciences Ag | Device for quantitative analysis of a metabolite profile |
| US20090148460A1 (en) * | 2005-07-08 | 2009-06-11 | Alain Delcayre | Exosome ligands, their preparation and uses |
| CN102533966B (en) | 2005-08-01 | 2014-03-12 | 俄亥俄州立大学研究基金会 | Micro-RNA-based methods and compositions for diagnosis, prognosis and treatment of breast cancer |
| WO2007072220A2 (en) | 2005-09-12 | 2007-06-28 | Aurelium Biopharma Inc. | Focused microarray and methods of diagnosing cancer |
| US8367627B2 (en) | 2005-09-15 | 2013-02-05 | Duke University | Focused libraries, functional profiling, laser SELEX, and DESELEX |
| JP2009509171A (en) | 2005-09-21 | 2009-03-05 | シーシーシー ダイアグノスティックス， エルエルシー | Comprehensive diagnostic trial for personalized anticancer chemotherapy (PAC) |
| EP1945802A1 (en) * | 2005-10-12 | 2008-07-23 | Erasmus University Medical Center Rotterdam | Method to diagnose or screen for inflammatory diseases |
| US20070092882A1 (en) | 2005-10-21 | 2007-04-26 | Hui Wang | Analysis of microRNA |
| ES2324435B1 (en) | 2005-10-27 | 2010-05-31 | Fundacion Para El Estudio De La Hematologia Y Hemoterapia De Aragon (Fehha) | PROCEDURE AND DEVICE OF IN VITRO MRNA ANALYSIS OF GENES INVOLVED IN HEMATOLOGICAL NEOPLASIAS. |
| AU2006308847C1 (en) * | 2005-10-31 | 2012-05-10 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for treating and diagnosing cancer |
| WO2007067813A2 (en) | 2005-12-09 | 2007-06-14 | Fox Chase Cancer Center | Methods and compositions for assessing alterations in gene expression patterns in clinically normal tissues obtained from heterozygous carriers of mutant genes associated with cancer and methods of use thereof |
| TWI274040B (en) | 2005-12-23 | 2007-02-21 | Ind Tech Res Inst | Microfluidic device and method of manufacturing the same |
| JP2007175021A (en) | 2005-12-28 | 2007-07-12 | Sysmex Corp | Lymph node metastasis marker of colon cancer |
| ES2554531T3 (en) * | 2006-01-05 | 2015-12-21 | The Ohio State University Research Foundation | Procedures based on microRNAs for the diagnosis, prognosis and treatment of lung cancer |
| JP5490413B2 (en) * | 2006-01-05 | 2014-05-14 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | Abnormal microRNA expression in pancreatic endocrine and acinar tumors |
| US7568399B2 (en) | 2006-01-05 | 2009-08-04 | Integrated Sensing Systems, Inc. | Microfluidic device |
| US7581429B2 (en) | 2006-01-06 | 2009-09-01 | Integrated Sensing Systems, Inc. | Microfluidic device and method of operation |
| US7593913B2 (en) | 2006-01-11 | 2009-09-22 | Siemens Medical Solutions Usa, Inc. | Systems and method for integrative medical decision support |
| WO2007084962A2 (en) * | 2006-01-18 | 2007-07-26 | The Regents Of The University Of California | A fluid membrane-based ligand display system for live cell assays and disease diagnosis applications |
| DK1994410T3 (en) | 2006-01-31 | 2011-01-31 | Medical Res Fund Of Tel Aviv Sourasky Medical Ct | Methods and kits for early detection of cancer or disposition therefore |
| US9198981B2 (en) | 2006-02-01 | 2015-12-01 | The University Of Kentucky | Modulation of angiogenesis |
| NZ545243A (en) | 2006-02-10 | 2009-07-31 | Pacific Edge Biotechnology Ltd | Urine gene expression ratios for detection of cancer |
| ES2300176B1 (en) | 2006-02-15 | 2009-05-01 | Consejo Superior Investig. Cientificas | METHOD FOR THE MOLECULAR PROSTATE CANCER DIAGNOSIS, KIT TO IMPLEMENT THE METHOD. |
| EP1984735B1 (en) | 2006-02-16 | 2010-10-06 | Ventana Medical Systems, Inc. | Reagents and methods for cancer prognosis and pathological staging |
| CA2638844C (en) | 2006-03-02 | 2016-05-03 | Thomas D. Schmittgen | Microrna expression profile associated with pancreatic cancer |
| EP3517151B1 (en) | 2006-03-09 | 2021-04-21 | Aethlon Medical, Inc. | Extracorporeal removal of microvesicular particles |
| JP2009529329A (en) * | 2006-03-09 | 2009-08-20 | トラスティーズ オブ ボストン ユニバーシティ | Methods for diagnosis and prognosis for lung diseases using gene expression profiles of nasal epithelial cells |
| US7908091B2 (en) | 2006-03-17 | 2011-03-15 | Prometheus Laboratories Inc. | Methods of predicting and monitoring tyrosine kinase inhibitor therapy |
| CA2646329C (en) * | 2006-03-20 | 2018-07-03 | The Regents Of The University Of California | Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting |
| BRPI0709340A2 (en) | 2006-03-27 | 2013-04-16 | Globeimmune Inc | mutations and compositions and methods of use thereof |
| WO2007114896A2 (en) | 2006-03-31 | 2007-10-11 | Ordway Research Institute | Prognostic and diagnostic method for cancer therapy |
| US20090098538A1 (en) | 2006-03-31 | 2009-04-16 | Glinsky Gennadi V | Prognostic and diagnostic method for disease therapy |
| US20070238118A1 (en) | 2006-04-06 | 2007-10-11 | Ambion, Inc. | Methods and kits for sequentially isolating rna and genomic dna from cells |
| US8758991B2 (en) | 2006-04-26 | 2014-06-24 | University Of Louisville Research Foundation, Inc. | Isolation of membrane vesicles from biological fluids and methods of using same |
| US9085778B2 (en) | 2006-05-03 | 2015-07-21 | VL27, Inc. | Exosome transfer of nucleic acids to cells |
| IL282783B2 (en) | 2006-05-18 | 2023-09-01 | Caris Mpi Inc | System and method for determining individualized medical intervention for a disease state |
| EP2589668A1 (en) | 2006-06-14 | 2013-05-08 | Verinata Health, Inc | Rare cell analysis using sample splitting and DNA tags |
| US8288369B2 (en) | 2006-06-27 | 2012-10-16 | University Of South Florida | Delta-tocotrienol treatment and prevention of pancreatic cancer |
| US20080014598A1 (en) | 2006-07-13 | 2008-01-17 | Cell Signaling Technology, Inc. | Phospho-specific antibodies to pi3k regulatory subunit and uses thereof |
| WO2008009002A2 (en) | 2006-07-13 | 2008-01-17 | Cell Signaling Technology, Inc. | Reagents for the detection of protein phosphorylation in signaling pathways |
| US20100003189A1 (en) | 2006-07-14 | 2010-01-07 | The Regents Of The University Of California | Cancer biomarkers and methods of use thereof |
| CA2660857A1 (en) | 2006-08-17 | 2008-02-21 | Ordway Research Institute, Inc. | Prognostic and diagnostic method for disease therapy |
| US20090280493A1 (en) | 2006-09-08 | 2009-11-12 | Siemens Healthcare Diagnostics Inc. | Methods and Compositions for the Prediction of Response to Trastuzumab Containing Chemotherapy Regimen in Malignant Neoplasia |
| MX2009002936A (en) | 2006-09-19 | 2009-04-01 | Novartis Ag | Biomarkers of target modulation, efficacy, diagnosis and/or prognosis for raf inhibitors. |
| CA2667521A1 (en) | 2006-10-27 | 2008-05-15 | George Mason Intellectual Properties, Inc. | Assay for metastatic colorectal cancer |
| EP2092075A2 (en) | 2006-11-06 | 2009-08-26 | Source Precision Medicine, Inc. | Gene expression profiling for identification, monitoring and treatment of melanoma |
| US7462489B2 (en) | 2006-11-09 | 2008-12-09 | Ley Klaus F | Methods for identifying and analyzing biomarkers from plasma-derived microparticles |
| US20100196889A1 (en) | 2006-11-13 | 2010-08-05 | Bankaitis-Davis Danute M | Gene Expression Profiling for Identification, Monitoring and Treatment of Colorectal Cancer |
| EP2087140A2 (en) | 2006-11-13 | 2009-08-12 | Source Precision Medicine, Inc. | Gene expression profiling for identification, monitoring, and treatment of lung cancer |
| WO2008060620A2 (en) | 2006-11-15 | 2008-05-22 | Gene Network Sciences, Inc. | Systems and methods for modeling and analyzing networks |
| CA2672270A1 (en) | 2006-12-15 | 2008-06-26 | Gennadi V. Glinksy | Treatments of therapy resistant diseases and drug combinations for treating the same |
| EP2094719A4 (en) | 2006-12-19 | 2010-01-06 | Genego Inc | Novel methods for functional analysis of high-throughput experimental data and gene groups identified therfrom |
| US20100055723A1 (en) * | 2007-01-23 | 2010-03-04 | University Of Virginia Patent Foundation | Galectin-3-Binding Protein as a Biomarker of Cardiovascular Disease |
| AU2008207735B2 (en) * | 2007-01-26 | 2013-10-03 | University Of Louisville Research Foundation, Inc. | Modification of exosomal components for use as a vaccine |
| ES2378490T3 (en) * | 2007-01-26 | 2012-04-13 | University Of Louisville Research Foundation, Inc. | Autoantibody detection methods to diagnose and characterize disorders |
| CN105256004A (en) * | 2007-01-31 | 2016-01-20 | 俄亥俄州立大学研究基金会 | Microrna-based methods and compositions for the diagnosis, prognosis and treatment of acute myeloid leukemia |
| US20090246289A1 (en) | 2007-02-06 | 2009-10-01 | Robert Superko | System and method for diagnosing and managing those at risk for cardiovascular disease |
| WO2008099280A2 (en) | 2007-02-15 | 2008-08-21 | Universita' Degli Studi Di Torino | Regulation of expression of pi3kb protein in tumors |
| MX2009009379A (en) | 2007-03-02 | 2009-09-14 | Amgen Inc | Methods and compositions for treating tumor diseases. |
| WO2008112283A2 (en) | 2007-03-12 | 2008-09-18 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Microrna profiling of androgen responsiveness for predicting the appropriate prostate cancer treatment |
| DK2412828T3 (en) | 2007-03-13 | 2013-09-02 | Amgen Inc | K-ras and B-raf mutations and anti-EGFr antibody treatment |
| SI2465950T1 (en) | 2007-03-13 | 2017-11-30 | Amgen Inc. | K-ras mutations and anti-egfr antibody therapy |
| CA2680591A1 (en) | 2007-03-15 | 2008-09-25 | Genomic Health, Inc. | Gene expression markers for prediction of patient response to chemotherapy |
| WO2008115556A2 (en) | 2007-03-19 | 2008-09-25 | Cold Spring Harbor Laboratory | Identification of genetic alterations that modulate drug sensitivity in cancer treatments |
| WO2008121132A2 (en) | 2007-03-30 | 2008-10-09 | Source Precision Medicine, Inc. D/B/A Source Mdx | Gene expression profiling for identification, monitoring, and treatment of prostate cancer |
| AU2007350900A1 (en) | 2007-04-05 | 2008-10-16 | Source Precision Medicine, Inc. | Gene expression profiling for identification, monitoring and treatment of ovarian cancer |
| AU2007350901A1 (en) | 2007-04-05 | 2008-10-16 | Source Precision Medicine, Inc. | Gene expression profiling for identification, monitoring, and treatment of breast cancer |
| EP2145024A2 (en) | 2007-04-06 | 2010-01-20 | Source Precision Medicine, Inc. | Gene expression profiling for identification, monitoring, and treatment of cervical cancer |
| EP2145902A3 (en) | 2007-04-19 | 2010-09-29 | Peter Hornbeck | Tyrosine phosphorylation sites and antibodies specific for them |
| WO2008138578A2 (en) | 2007-05-11 | 2008-11-20 | Medical Prognosis Institute | Methods, kits, and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy |
| EP2183386A1 (en) | 2007-05-31 | 2010-05-12 | Yale University | A genetic lesion associated with cancer |
| US20090104649A1 (en) | 2007-06-11 | 2009-04-23 | Garovic Vesna D | Markers for preeclampsia |
| CN101815793A (en) | 2007-06-15 | 2010-08-25 | 南佛罗里达大学 | Methods of diagnosing and treating cancer |
| CA3056116A1 (en) | 2007-06-22 | 2008-12-31 | Randolph Watnick | Methods and uses thereof of prosaposin |
| WO2009015357A1 (en) * | 2007-07-25 | 2009-01-29 | University Of Louisville Research Foundation, Inc. | Exosome-associated microrna as a diagnostic marker |
| EP2191276B1 (en) | 2007-08-03 | 2013-11-20 | DKFZ Deutsches Krebsforschungszentrum | Method for prenatal diagnosis using exosomes and cd24 as a marker |
| US9186405B2 (en) | 2007-08-16 | 2015-11-17 | The Royal Institution For The Advancement Of Learning/Mcgill University | Tumor cell-derived microvesicles |
| GB0716804D0 (en) | 2007-08-29 | 2007-10-10 | Univ Court Of The University O | Identifying organ damage |
| US8076061B2 (en) | 2007-09-07 | 2011-12-13 | Ascentgene, Inc. | Method and composition for cancer diagnosis and treatment |
| JP2009077712A (en) | 2007-09-11 | 2009-04-16 | F Hoffmann La Roche Ag | Diagnostic test for sensitivity to B-Raf kinase inhibitors |
| BRPI0816852A2 (en) | 2007-09-14 | 2017-06-06 | Univ Ohio State Res Found | method of diagnosing or predicting disease or disorder in subject, biomarker, method for determining and / or predicting whether subject has disorder differentiation, biomarker for lung disorder, method for diagnosing if subject has, or is at risk of developing disease or disorder, method inhibit the proliferation of disease or disorder and method to identify cancer therapeutic agent. |
| WO2009052573A1 (en) | 2007-10-23 | 2009-04-30 | Clinical Genomics Pty. Ltd. | A method of diagnosing neoplasms |
| WO2009061297A1 (en) | 2007-11-06 | 2009-05-14 | Source Precision Medicine, Inc. | Gene expression profiling for identification of cancer |
| GB2460769C (en) | 2007-11-30 | 2011-09-07 | Applied Genomics Inc | TLE3 as a marker for chemotherapy |
| AU2008329755A1 (en) | 2007-11-30 | 2009-06-04 | The Ohio State University Research Foundation | MicroRNA expression profiling and targeting in peripheral blood in lung cancer |
| WO2009086203A2 (en) | 2007-12-27 | 2009-07-09 | Aethlon Medical, Inc. | Method and apparatus for increasing contaminant clearance rates during extracorporeal fluid treatment |
| US8617806B2 (en) | 2008-01-25 | 2013-12-31 | Hansabiomed Ou | Method to measure and characterize microvesicles in the human body fluids |
| CA2713469A1 (en) | 2008-02-01 | 2009-08-06 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions relating to carcinoma stem cells |
| ES2936256T3 (en) * | 2008-02-01 | 2023-03-15 | Massachusetts Gen Hospital | Use of microvesicles in the diagnosis, and prognosis of diseases and medical conditions |
| EP2247756A2 (en) | 2008-02-21 | 2010-11-10 | Université Libre de Bruxelles | Method and kit for the detection of genes associated with pik3ca mutation and involved in pi3k/akt pathway activation in the er-positive and her2-positive subtypes with clinical implications |
| GB0803192D0 (en) | 2008-02-22 | 2008-04-02 | Mubio Products Bv | SCLC biomarker panel |
| EP2799557B1 (en) | 2008-02-28 | 2016-09-07 | The Ohio State University Research Foundation | MiR-32 antagonists for increasing responsiveness of prostate cancer to apoptosis |
| EP2105511A1 (en) | 2008-03-28 | 2009-09-30 | Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. | Medicament compositions and substances for treatment and identifying adenocarcinoma of the lung |
| US20110053804A1 (en) | 2008-04-03 | 2011-03-03 | Sloan-Kettering Institute For Cancer Research | Gene Signatures for the Prognosis of Cancer |
| WO2009126160A1 (en) | 2008-04-10 | 2009-10-15 | University Of Florida Research Foundation | Compositions and methods for the treatment of prostate carcinoma |
| US20090269773A1 (en) | 2008-04-29 | 2009-10-29 | Nodality, Inc. A Delaware Corporation | Methods of determining the health status of an individual |
| DK2568053T3 (en) | 2008-05-12 | 2014-07-21 | Genomic Health Inc | TESTS FOR PREVENTING THE RESPONSE OF CANCER PATIENTS ON DIFFERENT CHEMOTHERAPEUTIC TREATMENTS |
| WO2009147519A1 (en) | 2008-06-06 | 2009-12-10 | Centre National De La Recherche Scientifique - Cnrs- | Use of endo-lysosomal system and secreted vesicles (exosome-like) in treatments and diagnostics based on small rna and experimental study of small rna |
| WO2009155505A2 (en) * | 2008-06-20 | 2009-12-23 | Proxy Life Science Holdings, Inc. | Microvesicle-based compositions and methods |
| US20100069298A1 (en) * | 2008-09-16 | 2010-03-18 | Robert Penny | Methods for Detecting Overexpression of SPARC and Therapeutic and Diagnostic Methods Relating to Same |
| US20110190383A1 (en) | 2008-09-18 | 2011-08-04 | The Ohio State University | Diagnostic, Prognostic and Therapeutic Uses of MIRs in Adaptive Pathways and/or Disease Pathways |
| US10545149B2 (en) * | 2008-10-06 | 2020-01-28 | Morehouse School Of Medicine | Detection of HIV-related proteins in urine |
| CN102301002A (en) * | 2008-11-12 | 2011-12-28 | 卡里斯生命科学卢森堡控股有限责任公司 | Methods and systems for determining phenotypes using exosomes |
| WO2010065968A1 (en) | 2008-12-05 | 2010-06-10 | Myriad Genetics, Inc. | Cancer detection markers |
| GB0822836D0 (en) * | 2008-12-15 | 2009-01-21 | Oxford Biomedica Ltd | Method |
| EP2202522A1 (en) | 2008-12-23 | 2010-06-30 | Universiteit Leiden | Methods for immobilizing microvesicles, means and methods for detecting them, and uses thereof |
-
2009
- 2009-11-12 CN CN2009801541083A patent/CN102301002A/en active Pending
- 2009-11-12 GB GB0921348.9A patent/GB2463401B/en not_active Expired - Fee Related
- 2009-11-12 EP EP20140153848 patent/EP2730662A1/en not_active Ceased
- 2009-11-12 US US12/591,226 patent/US7897356B2/en not_active Expired - Fee Related
- 2009-11-12 EP EP17154244.2A patent/EP3181705A1/en not_active Withdrawn
- 2009-11-12 CA CA2743211A patent/CA2743211A1/en not_active Abandoned
- 2009-11-12 CN CN201710603889.6A patent/CN107254538A/en active Pending
- 2009-11-12 JP JP2011536326A patent/JP2012508577A/en active Pending
- 2009-11-12 EP EP09826433A patent/EP2350320A4/en not_active Withdrawn
- 2009-11-12 WO PCT/US2009/006095 patent/WO2010056337A2/en not_active Ceased
- 2009-11-12 BR BRPI0921043A patent/BRPI0921043A2/en not_active IP Right Cessation
-
2010
- 2010-02-05 US US12/658,452 patent/US20100203529A1/en not_active Abandoned
-
2011
- 2011-01-19 US US13/009,285 patent/US8211653B2/en not_active Expired - Fee Related
- 2011-01-19 US US13/009,393 patent/US8278059B2/en not_active Expired - Fee Related
- 2011-05-08 IL IL212768A patent/IL212768A/en not_active IP Right Cessation
-
2012
- 2012-07-06 US US13/543,315 patent/US20130005599A1/en not_active Abandoned
-
2014
- 2014-06-08 IL IL233023A patent/IL233023A/en not_active IP Right Cessation
-
2015
- 2015-07-29 JP JP2015149325A patent/JP2016028572A/en active Pending
-
2016
- 2016-03-20 IL IL244689A patent/IL244689A0/en unknown
- 2016-12-29 US US15/394,684 patent/US20170108503A1/en not_active Abandoned
-
2017
- 2017-05-15 JP JP2017096158A patent/JP2017167157A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114214419A (en) * | 2020-03-30 | 2022-03-22 | 中国医学科学院肿瘤医院 | Kit, device and method for diagnosis of lung cancer |
| CN114214419B (en) * | 2020-03-30 | 2023-06-27 | 中国医学科学院肿瘤医院 | Application of exosome miR-3615, MBOAT2 and the like in lung cancer diagnosis |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2730662A1 (en) | 2014-05-14 |
| GB2463401A8 (en) | 2013-05-15 |
| CN107254538A (en) | 2017-10-17 |
| WO2010056337A2 (en) | 2010-05-20 |
| EP2350320A4 (en) | 2012-11-14 |
| US20110237450A1 (en) | 2011-09-29 |
| BRPI0921043A2 (en) | 2018-08-07 |
| IL233023A (en) | 2016-03-31 |
| US7897356B2 (en) | 2011-03-01 |
| IL212768A (en) | 2014-07-31 |
| US8278059B2 (en) | 2012-10-02 |
| US20100184046A1 (en) | 2010-07-22 |
| US20100203529A1 (en) | 2010-08-12 |
| GB2463401B (en) | 2014-01-29 |
| EP3181705A1 (en) | 2017-06-21 |
| US20110151460A1 (en) | 2011-06-23 |
| IL244689A0 (en) | 2016-04-21 |
| HK1142371A1 (en) | 2010-12-03 |
| US8211653B2 (en) | 2012-07-03 |
| GB2463401A (en) | 2010-03-17 |
| JP2012508577A (en) | 2012-04-12 |
| IL233023A0 (en) | 2014-07-31 |
| EP2350320A2 (en) | 2011-08-03 |
| WO2010056337A3 (en) | 2010-09-10 |
| CA2743211A1 (en) | 2010-05-20 |
| IL212768A0 (en) | 2011-07-31 |
| JP2017167157A (en) | 2017-09-21 |
| US20130005599A1 (en) | 2013-01-03 |
| CN102301002A (en) | 2011-12-28 |
| JP2016028572A (en) | 2016-03-03 |
| US20170108503A1 (en) | 2017-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0921348D0 (en) | No title | |
| GB0911515D0 (en) | No title | |
| GB201001457D0 (en) | No title | |
| GB0905250D0 (en) | No Title | |
| GB0817849D0 (en) | No title | |
| GB201102451D0 (en) | No title | |
| GB0803497D0 (en) | No title | |
| GB0823692D0 (en) | No title | |
| GB201005302D0 (en) | No title | |
| GB0812812D0 (en) | No title | |
| GB0720426D0 (en) | No Title | |
| GB201003022D0 (en) | No title | |
| GB0720427D0 (en) | No title | |
| GB0915545D0 (en) | No title | |
| GB0917233D0 (en) | No title | |
| GB0919192D0 (en) | No title | |
| GB0917991D0 (en) | no title | |
| GB0805249D0 (en) | No title | |
| GB0914968D0 (en) | No title | |
| GB0915739D0 (en) | No Title | |
| GB0805256D0 (en) | No title | |
| GB0804746D0 (en) | No title | |
| GB0810281D0 (en) | No title | |
| GB0813676D0 (en) | No title | |
| GB0723145D0 (en) | No title |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1142371 Country of ref document: HK |
|
| 732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) |
Free format text: REGISTERED BETWEEN 20130215 AND 20130220 |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1142371 Country of ref document: HK |
|
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20171112 |